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Abstract 
 
Glaucoma affects tens of millions of people and is the leading cause of irreversible 
blindness worldwide. Virtually all current glaucoma therapies target elevated intraocular 
pressure (IOP); however, the contribution of intracranial pressure (ICP) to glaucoma has 
recently garnered interest. Strain at the optic nerve head is now known to depend on the 
translaminar pressure difference (TLPD), which is the difference between IOP and ICP, 
rather than IOP alone. A better understanding of how IOP and ICP relate to glaucoma 
development and progression is essential for developing improved therapies and 
diagnostic tests. Glaucoma is commonly modeled in rats, yet aqueous humor dynamics 
are not well-documented in healthy nor diseased rat eyes. Moreover, because rats do not 
develop glaucoma spontaneously, it is essential to develop low-cost, reliable, and 
relevant models of glaucomatous pathology in the animal. 
The purpose of this dissertation work is to achieve the following goals: i) 
quantitatively assess aqueous humor dynamics in healthy, living rat eyes, ii) develop an 
ideal model of experimental glaucoma in rats, iii) quantitatively characterize aqueous 
humor dynamics throughout experimental glaucoma in living rats, and iv) investigate the 
effects of ICP manipulations on aqueous humor dynamics in living rats. Chapter 2 reports 
physiological parameters of aqueous humor dynamics for the first time in the eyes of 
living, healthy Brown-Norway rats, and presents a novel perfusion technique for efficiently 
and accurately estimating these parameters. Chapter 3 introduces the constant-pressure 
vii 
perfusion model of experimental glaucoma: a powerful new model which overcomes 
several limitations of existing techniques. The constant-pressure perfusion model induces 
IOP elevations which are prescribable and easily manipulated, does not directly target 
the trabecular meshwork or its vasculature, and offers continuous records of IOP rather 
than requiring regular animal handling and tonometry. Chapter 3 characterizes IOP-
induced optic neuropathies in rats and demonstrates their resemblance to human 
glaucoma. Chapter 4 evaluates whether the constant-pressure perfusion model affects 
ocular physiology, specifically showing that resting IOP and conventional outflow facility 
are not permanently nor significantly altered in the model. Chapter 5 examines the effect 
of ICP manipulations on aqueous outflow physiology in living rats, and reports for the first 
time a graded effect of intracranial hypertension on conventional outflow facility. Evidence 
for a neural feedback mechanism that may serve to regulate the TLPD is also presented. 
Chapter 6 summarizes the results of this dissertation, provides recommendations for 
future work, and gives closing remarks. 
These collective projects provide insight into IOP regulation in both healthy and 
diseased rat eyes, advancing our understanding of glaucomatous development and 
damage in rats. A novel model of experimental glaucoma and several perfusion systems 
have been developed which are distinctly tailored for use in future glaucoma studies and 
will allow future investigators to study the disease with enhanced efficiency and 
exactitude. The results of this dissertation work suggest that detecting and correcting 
impairments of either IOP or ICP homeostatic capabilities may be of utmost importance 
for improving clinical outcomes in human glaucoma.  
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Chapter 1: Introduction 
 
1.1 Intraocular Pressure Regulation 
Intraocular pressure (IOP) describes fluid pressure within the eye. In humans, IOP 
averages approximately 15 mmHg (Millar and Kaufman, 1995) and is considered normal 
between 10 to 21 mmHg (Giuffrè et al., 1995; Leibowitz et al., 1980; Klein et al., 1992; 
Dielemans et al., 1994; Bonomi et al., 1998). IOP must be tightly controlled to support 
normal ocular and visual health, as IOP that is abnormally low can distort the cornea, 
lens, or retina to impair vision, while IOP that is abnormally high can injure visual neurons 
resulting in irreversible blindness (Quigley et al., 1982). Homeostatic IOP is achieved by 
a dynamic balance of aqueous humor inflow and outflow in the anterior segment of the 
eye. Aqueous humor is a watery, clear, plasma-like fluid, notwithstanding its low protein 
concentration. Aqueous humor is continuously produced in the ciliary epithelium at a 
relatively IOP-insensitive rate and secreted to fill the posterior and anterior chambers of 
the eye (Brubaker, 1970). At steady-state IOP, aqueous humor production is balanced by 
aqueous humor outflow, which occurs via two distinct routes: the conventional and 
unconventional outflow pathways (Bill, 1965; Bill, 1966).  
1.2 Pathways of Aqueous Humor Drainage 
The conventional outflow pathway is defined by a series of physical structures. 
This pathway courses through a porous, spongy tissue called the trabecular meshwork, 
through Schlemm’s canal, and ultimately into the episcleral venous system (Gong et al., 
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1996; Tamm, 2009). Aqueous humor is forced through the conventional outflow pathway 
by the pressure gradient generated by IOP and episcleral venous pressure. The 
unconventional outflow pathway describes all other routes of aqueous humor drainage 
(Bill, 1965; Bill, 1966). This pathway involves pressure-insensitive aqueous humor 
seepage across the iris, ciliary muscle, and sclera (Alm and Nilsson, 2009; Johnson et 
al., 2017; Johnson, 2006; Bill, 1966). 
Under normal conditions, the conventional outflow pathway presents the primary 
resistance to aqueous humor outflow (Bill and Maepea, 1994; Schachtschabel et al., 
2000; Weinreb, 2000, Weinreb et al., 2002; Acott and Kelly, 2008). Because the rate of 
aqueous humor production is relatively constant and aberrant production is clinical rare 
(Sachdev et al., 1988), IOP is primarily regulated by modulation of conventional outflow 
resistance (Acott and Kelly, 2008; Acott et al., 2014; Brubaker, 1970: Brubaker, 1991). 
The resistance of the conventional outflow pathway is measurable and usually expressed 
as its reciprocal: conductance, or conventional outflow facility. 
In summary, IOP is regulated by the dynamic relationship between conventional 
outflow facility (C), unconventional outflow rate (Fun), aqueous humor production rate (Fin), 
and episcleral venous pressure (EVP). The explicit relationship between these 
parameters is described by the Goldmann equation (Brubaker, 2004), which is presented 
in a modified form in Equation 4 of Appendix D. 
1.3 Glaucoma 
The retina is responsible for detecting light and relaying visual information. 
Specifically, neural signals are transmitted from the eye towards the brain by retinal 
ganglion cell (RGC) axons. RCG axons exit the eye posteriorly through a mesh-like 
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structure called the lamina cribosa and converge to form the optic nerve. Glaucoma is a 
group of heterogeneous optic nerve neuropathies characterized by progressive RGC 
death and distinct patterns of visual field loss. By 2020, glaucoma is predicted to affect 
79.6 million people and cause bilateral blindness in 11.1 million of these individuals 
(Quigley and Broman, 2006); thus, glaucoma is the leading cause of irreversible blindness 
worldwide (Quigley, 2011).  
Significant risk factors for glaucoma include age (Gordon et al., 2002; Leske et al., 
2001), family history (Le et al., 2003; Leske et al., 2008), ethnicity (Tielsch et al., 1991; 
Leske et al., 1994), and elevated IOP (Leske et al., 1994; Banks et al., 1968; Tielsch et 
al., 1991; Sommer et al., 1991; Weih, et al., 2001; Dielemans et al., 1994; Mitchell et al., 
1996; Quigley et al., 2001). Of these risk factors, only elevated IOP is modifiable. 
Reducing IOP reduces both the probability and rate of visual field loss and is thus the 
target of virtually all glaucoma therapies (Heijl, et al., 2002; Kass et al., 2002). In 
glaucoma, elevated IOP is thought to result from trabecular meshwork clogging or 
stiffening (Last et al., 2011). When IOP exceeds physiological levels, optic nerve cupping 
can be observed and RGC axons at the lamina cribosa are subject to mechanical stress 
and strain (Bellezza et al., 2003; Pena et al., 2001). Furthermore, the risk for 
glaucomatous neural injury has been shown to increase with increasing IOP (Quigley et 
al., 1982). The magnitude of IOP elevations and rate of their onset depend on the form of 
glaucoma expressed in an individual.  
The most prevalent form of glaucoma is primary open-angle glaucoma (POAG) 
(Quigley and Broman, 2006). In POAG, trabecular meshwork resistance gradually 
increases; thus, the disease is characterized by slowly and subtly increasing IOP 
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(Weinreb, 2004). The iridocorneal angle appears clinically normal in POAG and is “open” 
to aqueous humor outflow through the trabecular meshwork, albeit at a reduced rate. 
POAG typically develops in adulthood and is asymptomatic until its advanced stages, 
after significant and irreversible RGC loss has occurred (Weinreb, 2004). Another 
prevalent form of glaucoma is primary angle-closure glaucoma (PACG). PACG differs 
from POAG because it presents with an abnormal iridocorneal angle. PACG is 
characterized by contact between the iris and trabecular meshwork, which obstructs 
aqueous humor outflow and can result in rapid, significant, and often painful IOP 
elevations (Wright et al., 2016). Not all forms of glaucoma are associated with elevated 
IOP, however. Normal tension glaucoma (NTG) is a common form of open-angle 
glaucoma which mimics POAG despite IOP falling within normal limits (Shields, 2008). 
1.4 Animal Models of Glaucoma 
Animal models of glaucoma advance our understanding of the pathogenesis and 
pathophysiology of the disease (Chew et al., 1996). Glaucoma models have been 
established for non-human primates, dogs, pigs, rabbits, rats, and mice. Some of these 
animals develop glaucoma spontaneously (Bouhenni et al., 2012). For example, a genetic 
mutation in the DBA/2J mouse causes shedding of iris pigment which ultimately clogs the 
conventional outflow pathway (John, 2005). This outflow obstruction causes moderate 
IOP elevations and associated RGC death starting around six months of age (Schuettauf 
et al., 2004). While the spontaneous onset of IOP elevation is opportune for some 
research purposes, several limitations are inherent to genetic models. For example, 
spontaneous IOP elevations develop bilaterally, therefore, an internal control group for 
hypothesis testing is lacking. Furthermore, the magnitude and rate of IOP elevations are 
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neither adjustable nor certain. Consequently, developing experimental models of 
glaucoma in otherwise healthy animals is often a goal for scientific investigators. 
 Several experimental glaucoma models have been developed in rats. Rats are 
commonly investigated due to their low cost, quick growth to sexual maturity, short 
lifespan, and ease of handling. Moreover, like humans, rats have a trabecular meshwork 
and Schlemm’s canal (van der Zypen, 1977; Daimon, 1997). Existing rat glaucoma 
models involve inducing ocular hypertension via methods such as microbead injection 
into the anterior chamber (Sappington et al., 2010), hypertonic saline injection into the 
episcleral veins (Morrison et al., 1997), laser photocoagulation of the trabecular 
meshwork (Ueda et al., 1998), cauterization of episcleral veins (Shareef et al., 1995), and 
circumlimbal suture application (Liu et al., 2015). These techniques aim to increase the 
resistance of the conventional outflow pathway or mechanically compress the eye to 
elevate IOP.  
While rat glaucoma models are widely used, the limitations of current models must 
also be recognized (Morrison, et al., 2005). Existing models and their limitations will be 
described in depth in Chapter 3. Briefly and in general, limitations of current glaucoma 
models include the following: ocular hypertension is typically induced by injuring the 
trabecular meshwork or its vasculature, IOP cannot be precisely prescribed or simply 
manipulated, often multiple interventions are required, IOP elevations are not stable nor 
permanent but slowly degrade over time, and IOP must be regularly monitored by 
tonometry. There is a need for improved glaucoma models which overcome the limitations 
outlined above.  
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1.5 Cerebrospinal Fluid Theory  
While visual field loss in most forms of glaucoma is associated with elevated IOP 
(Hollows and Graham, 1966), there are several conditions which contradict the direct 
causality of elevated IOP on glaucoma pathogenesis. For example, NTG and ocular 
hypertension, which is elevated IOP without evidence of glaucoma, do not follow the 
straightforward model of elevated IOP activating glaucomatous pathology. Evidently, 
there are mechanisms of glaucomatous RGC damage which are IOP independent and 
not fully understood. Reduced intracranial pressure (ICP) has been suggested as an 
important risk factor for glaucoma (Berdahl et al., 2008b). Cerebrospinal fluid fills the 
ventricles of the brain and surrounds the brain, spinal cord, and optic nerve; therefore, 
the lamina cribosa is subject to a net balancing force determined by ICP and IOP. In 2010 
authors Berdahl and Allingham proposed cerebrospinal fluid theory (Berdahl and 
Allingham, 2010). The fundamental tenet of cerebrospinal fluid (CSF) theory is that the 
translaminar pressure difference (TLPD) rather than IOP alone determines stress at the 
optic nerve head. Essentially, this theory suggests that the lamina cribosa should be 
considered a membrane subject to posteriorly directed IOP and anteriorly directed ICP; 
and if either IOP or ICP homeostasis becomes interrupted, the TLPD will subsequently 
become aberrant and the risk for neural damage will increase.  
Since the early 2000s, several well-designed prospective and retrospective clinical 
studies, as well as numerous experimental animal studies, have supported ICP theory 
and suggested the role of reduced ICP as a significant risk factor for glaucoma. 
Specifically, ICP is reduced in patients with POAG and NTG (Berdahl et al., 2008a; 
Berdahl et al., 2008b, Chen et al., 2015), ICP is elevated in patients with ocular 
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hypertension who never develop glaucoma (Berdahl et al., 2008a; Berdahl et al., 2008b), 
experimentally lowering ICP induces glaucomatous neuropathy in monkeys and rats 
(Yang et al., 2014; Chowdhury et al., 2016), elevating ICP induces significant RGC death 
in mice (Nusbaum et al., 2015), ICP manipulations affect the electroretinogram (ERG) in 
rats (Zhao et al., 2015), IOP and ICP are correlated (Lehman et al., 1972; Hou et al., 
2016), and IOP and ICP are regulated by the same group of neurons, presumably within 
the hypothalamus of the brain (Samuels et al., 2012). Despite these findings, ICP’s role 
in glaucoma pathogenesis and the relationship between IOP and ICP remain unclear. 
Evidently, there is a need to investigate how ICP relates to glaucoma and its role ocular 
physiology. 
1.6 Overview of Dissertation 
 The dissertation addresses the following questions: i) What are the baseline values 
of physiological parameters of aqueous humor dynamics in healthy, living rat eyes? ii) 
Can we develop an enhanced glaucoma model which overcomes the limitations of 
existing techniques? iii) How are parameters of aqueous humor dynamics affected during 
experimental glaucoma? iv) What is the impact of aberrant ICP on aqueous humor 
dynamics? This dissertation is structured as four independent studies corresponding to 
their own chapter and each aimed at answering one of these questions. 
Chapter 2 contains a study previously published in Investigative Ophthalmology & 
Visual Science and involves quantitatively assessing aqueous humor dynamics in 
healthy, living rat eyes. We know that C becomes impaired in glaucoma; however, the 
exact mechanisms of disease pathogenesis and progression are not well-understood. 
Thoroughly understanding aqueous humor dynamics in healthy eyes is the first step 
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towards developing innovative and improved glaucoma therapies and is the goal of 
Chapter 2. This study also involves the development of a novel perfusion technique for 
accurately and efficiently estimating parameters of aqueous humor dynamics. Chapter 3 
describes a system for inducing chronic, prescribable, and easily modifiable IOP 
elevations in rats, without directly damaging the trabecular meshwork, and both 
quantitatively and qualitatively assesses the resulting optic neuropathies. The goal of this 
chapter is to develop a rat glaucoma model which overcomes the limitations of existing 
models and is tailored to future work associated with understanding mechanisms of 
disease progression and assaying potential treatments. Chapter 4 involves characterizing 
aqueous humor dynamics throughout experimental glaucoma. Nearly all existing 
glaucoma models rely on injuring the trabecular meshwork or its vasculature to slow 
conventional outflow and secondarily induce ocular hypertension. As a result, the effect 
of chronic ocular hypertension on otherwise healthy trabecular meshwork has not been 
previously investigated in living animals for extended durations. Chapter 5 presents a 
study to be submitted to Proceedings of the National Academy of Sciences of the United 
States of America (PNAS). This chapter investigates the effect of experimentally elevated 
ICP on aqueous humor dynamics in rats. Finally, chapter 6 summaries this work, makes 
recommendations for future experiments, and provides concluding remarks.  
The overall goal of this dissertation is to better understand normal and aberrant 
aqueous humor dynamics in rats, to advance our collective understanding of glaucoma, 
and to develop useful tools for future glaucoma studies.  
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Chapter 2: Aqueous Humor Dynamics of the Brown-Norway Rat 
 
2.1 Note to Reader 
 This study (Ficarrotta, K. R., Bello, S. A., Mohamed, Y. H. and Passaglia, C. L. 
(2018) 'Aqueous humor dynamics of the Brown-Norway rat', Invest Ophthalmol Vis Sci, 
59(6), pp. 2529-2537.) was published in Investigative Ophthalmology & Visual Science in 
May 2018. The published manuscript and its two supplemental figures are provided in 
Appendix D. 
2.2 Overview 
This study provides a quantitative description of aqueous humor dynamics in 
healthy Brown-Norway rats. Physiological parameters were estimated in live and dead 
eyes using a well-established constant flow (CF) technique and novel, modified constant-
pressure (mCP) perfusion technique. Both C and Fun were indistinguishable for the two 
perfusion techniques, providing experimental validation of the mCP technique to 
complement the mathematical derivations provided in the manuscript. C was 
indistinguishable in live and dead eyes when perfusions were repeated in-situ, which is a 
significant result that is exploited in Chapter 5 experiments. Outflow measurement 
accuracy was assessed by inserting a shunt of known conductance into the eye and 
measuring the resulting shift in C (ocular conductance). This is a novel approach to 
validating outflow measurement accuracy and bolstered confidence in the accuracy of 
our results. At 100% humidity, Fun became indistinguishable from zero, indicating potential 
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measurement complication due to evaporation. Physiological washout, which was 
previously thought to occur in all species other than humans and mice, was not observed; 
and trabecular meshwork anatomy appeared normal under light microscopy following 
perfusions.  
This study provides baseline values of the physiological parameters of aqueous 
humor dynamics in healthy, living rats and presents a novel perfusion technique for 
accurately estimating these parameters with improved efficiency. This methodology 
should be useful for investigating the effects of pharmacologic agents, experimental 
perturbations, or genetic manipulations on aqueous humor dynamics in rats and other 
animals. 
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Chapter 3: The Constant-Pressure Perfusion Model of Experimental Glaucoma in 
Brown-Norway Rats 
 
3.1 Introduction 
Various animals exhibit optic neuropathy similar to that observed in human 
glaucoma and can consequently be used to generate useful models (McKinnon et al., 
2009; Almasieh et al., 2012; Gaasterland and Kupfer, 1974; Quigley and Hohman, 1983; 
Ueda et al., 1998; Aihara et al., 2003). Because glaucoma does not develop 
spontaneously in rats, it is imperative to develop reproducible, low-cost techniques for 
experimentally inducing and subsequently studying glaucomatous pathology in the 
animal. Most commonly, animal models of glaucoma involve experimentally inducing 
ocular hypertension (Morrison et al., 2005). While not all forms of glaucoma clinically 
manifest with elevated IOP, elevated IOP is the only modifiable risk factor for which 
current glaucoma therapies are directed (Morrison et al., 2005). Additionally, the risk of 
developing glaucomatous optic neuropathy increases with IOP elevation (Quigley et al., 
1982), while reducing IOP reduces the probability and rate of visual field loss in both 
POAG and NTG (Drance, 1999; Leske et al., 2004). Therefore, it is reasonable to expect 
that patterns of pressure-induced optic nerve damage will relate to glaucoma progression 
and be useful for the development and assessment of potential treatments.  
12 
 Existing ocular hypertension induction techniques involve increasing the 
resistance of the conventional outflow pathway and chronically compressing the eye. 
Several commonly-used rat glaucoma models are described in more detail below.  
3.1.1 Rat Glaucoma Models 
3.1.1.1 Hypertonic Saline Injection Model 
 One popular method for inducing ocular hypertension in rats involves injecting 
hypertonic saline towards the limbus through an episcleral vein (Morrison et al., 1997). A 
plastic ring is positioned around the equator of the eye, with a small opening centered 
over one radial episcleral vein. Hypertonic saline (1.65M to 1.75M, 50 µl) is then injected 
into the exposed vein via a microsyringe connected to a glass microneedle. The plastic 
ring assists in forcing the hypertonic saline through Schlemm’s canal and the trabecular 
meshwork. The hypertonic saline causes an inflammatory response and subsequent 
scarring of the trabecular meshwork and iridocorneal angle, which reduces C (Morrison 
et al., 1997). Following the injection, IOP is regularly measured via bilateral tonometry. 
 The magnitude of and duration of IOP elevations induced via this technique 
depend on the extent of scarring, which cannot be precisely predetermined nor controlled 
following the injection procedure. Thus, IOP in the treated eye cannot be precisely 
prescribed nor easily manipulated. Moreover, IOP in the treated eye is largely variable. 
For example, in a group of 20 animals, IOP elevations varied from a minimum of 0 mmHg 
to a maximum of 28 ± 13 mmHg following injection of the same concentration and volume 
of hypertonic saline (Morrison et al., 1997). Furthermore, only 45% of rats developed 
significant IOP elevations following a single injection (Morrison et al., 1997). Subsequent 
injection procedures (typically two or three injections total) were required in most animals. 
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The onset of IOP elevation occurs within 7 to 10 days following a successful injection. 
Once elevated, IOP does not remain stable; instead, it begins to slowly return to its resting 
level after approximately 36 days even after three injection procedures.  
3.1.1.2 Episcleral Vein Cauterization Model 
 Another popular technique for inducing chronic IOP elevations in rats involves 
cauterizing one or more large episcleral veins (Sawada and Neufeld, 1999; Shareef et 
al.,1995). Typically, three of four episcleral veins are cauterized to obstruct their blood 
flow. Because aqueous humor ultimately drains into episcleral veins, cauterizing some of 
these veins increases the resistance of the conventional outflow pathway, thus elevating 
IOP. IOP response from this technique is measured via regular tonometry. Resulting IOP 
elevations usually occur immediately and do not require multiple procedures; however, 
the magnitude of IOP elevation degrades over time and can only be sustained for a 
maximum of six weeks (Shareef et al.,1995). More specifically, IOP becomes 
indistinguishable in treated and untreated eyes after two to four weeks in 30% of treated 
animals, which limits the technique’s utility in chronic glaucoma research (Ahmed et al., 
2001).  
3.1.1.3 Microbead Occlusion Model 
 Rather than altering ocular vasculature, the microbead occlusion method relies on 
obstructing the conventional outflow pathway with polystyrene microbeads (Sappington 
et al., 2010). Polystyrene microbeads in saline are injected directly into the anterior 
chamber via a microsyringe connected to a microneedle, and ultimately become lodged 
within structures of the conventional outflow pathway. The principal limitations associated 
with this method are success rate, degree of IOP elevation, and duration of IOP elevation. 
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Specifically, a single injection significantly elevates IOP in only 21% to 34% of rats and 
IOP elevations persist for only two weeks (Sappington et al., 2010). Following a second 
injection, IOP elevations can be sustained for up to eight weeks. The average IOP 
elevation is approximately 7.5 ± 1.0 mmHg. Milder IOP elevations can be achieved by 
reducing the volume of injected microbeads; however, increasing the injection volume 
does not elevate IOP beyond 7.5 mmHg. Several similar models have been developed 
using distinct particulates, such as ghost red blood cells (Quigley and Addicks, 1980) or 
latex microspheres (Weber and Zelenak, 2001), rather than polystyrene microbeads. 
3.1.1.4 Laser Photocoagulation of the Trabecular Meshwork 
 The laser photocoagulation model involves selectively burning the trabecular 
meshwork via direct laser photocoagulation to increase trabecular meshwork resistance 
and elevate IOP (Ueda et al., 1998). As with other current models, multiple interventions 
are often required, IOP must be measured via tonometry, and IOP elevations degrade 
over time. The original presentation of this method reports a 100% success rate in 
elevating IOP (7 of 7 animals), but required multiple interventions, required tonometry, 
showed signs of inflammatory responses, and could not sustain IOP elevations over time.  
3.1.1.5 Circumlimbal Suture Model 
 The circumlimbal suture implantation model was developed most recently (Liu et 
al., 2015). This technique is unique because it does not rely on reducing aqueous humor 
outflow through the conventional outflow pathway. Instead, a nylon suture is placed 
around the equator of the eye and secured by multiple anchor points in the 
subconjunctiva. Anchoring is achieved by threading the nylon suture under all radial 
episcleral veins. This subconjunctival anchoring serves to secure the suture to the surface 
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of the eye while preventing the obstruction of blood flow through episcleral veins. The 
suture is then tightened as desired and tied to compress the eye, thus elevating IOP. 
Resulting IOP elevations can persist for up to 15 weeks and, in the original presentation 
of this technique, average approximately 10 mmHg. The suture can be loosened to 
reverse IOP elevations at the conclusion of experiments, unlike any of the previously 
described techniques. The major limitations associated with this technique are that 
regular tonometry is required and, while IOP can be manipulated by loosening or 
tightening the suture, this requires surgical intervention.  
3.1.1.6 Characteristics of an Ideal Glaucoma Model 
 Developing models of experimental glaucoma requires methods for measuring 
IOP, inducing chronic ocular hypertension, and assessing resulting neuropathies 
(Morrison et al., 2005). Several characteristics of glaucoma models have been identified 
as desirable through extensive literature review. To begin, all existing rat glaucoma 
models rely on regular tonometry to monitor IOP. Tonometry is analogous to deducing 
the pressure inside a balloon palpating its surface. Tonometry provides discrete and 
sparse measurements of IOP, which cannot fully capture its intrinsic variability. An ideal 
model would provide an accurate and continuous record of IOP in real-time without 
requiring animal handling or regular intervention. Regarding ocular hypertension 
inductions, the number of interventions required to elevate IOP would ideally be 
minimized; and induced IOP elevations would be prescribable, immediate, unilateral, 
stable, sustainable, and easily manipulated. Perhaps the most important feature of an 
animal glaucoma model is its resemblance to human glaucoma; therefore, the ideal model 
must result in optic neuropathies which are distinctive of the disease, clinically. 
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3.1.2 Purpose  
 One goal of this dissertation is to characterize aqueous humor dynamics in 
glaucomatous rats. While not generally a requirement of an ideal glaucoma model, it was 
thus desirable to develop a model that does not involve directly injuring or altering 
structures of the conventional outflow pathway. If this is achieved, the conductance of 
otherwise healthy trabecular meshwork, or conventional outflow facility, can be 
characterized throughout experimental glaucoma for the first time in a meaningful way. 
 The purpose of this study is to develop the ideal rat glaucoma model. This chapter 
describes a powerful new technique for continuously measuring IOP and chronically 
elevating IOP to prescribable and easily modifiable levels without directly targeting the 
conventional outflow pathway. The whole number and distribution of RGCs are 
characterized for various durations of ocular hypertension in Brown-Norway rats.  
3.2 Methods 
 All experiments were conducted in accordance with the ARVO Statement for the 
use of Animals in Ophthalmic and Vision Research and in compliance with a protocol 
approved by the Institutional Animal Care and Use Committee at the University of South 
Florida. Experiments were performed on adult male Brown-Norway rats (300-400g) 
housed in a temperature-controlled room (21°C) under a 12-hour light/12-hour dark cycle 
with food and water available ad libitum.  
3.2.1 Ocular Hypertension Induction  
3.2.1.1 The Tethered Perfusion System  
 Ocular hypertension was induced by continuous perfusion of artificial aqueous 
humor (AAH, 130 mM NaCl, 5 mM KCl, 5 mM NaHCO3, 1 mM CaCl2, 0.5 mM MgCl2, 20 
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mM HEPES, pH 7.25) into the anterior chamber through a tethered perfusion system. The 
system consisted of an ocular cannula, pressure transducer, AAH reservoir, and 
computer. A fine polyimide tube (100μm ID, 140µm OD) filled with AAH was implanted in 
one anterior chamber (Bello et al., 2017) and connected via 25g polyethylene (PE) tubing 
to the pressure transducer and AAH reservoir. On the day of surgery, rats were 
anesthetized via an intraperitoneal injection of ketamine hydrochloride (75 mg/kg) and 
xylazine (7.5 mg/kg) supplemented as needed, placed on a warming pad, and mounted 
in a stereotaxic apparatus. The eye selected for implantation was instilled with mydriatic 
(1% cyclopentolate hydrochloride), and its eyelid was retracted, while the contralateral 
eye was covered with artificial tears ophthalmic ointment. The polyimide tube was 
tunneled subconjunctivally and subdermally to the input port of a custom designed 
coupler which was affixed to the skull via bone screws. The coupler (Delrin®, Interstate 
Plastics, Sacramento, CA) was designed using CAD software (SolidWorks, Waltham, 
MA) and machined in-house. The output port of the coupler was connected to 25g PE 
tubing surrounded by a metal spring. A schematic diagram of the coupler and its position 
on the skull are presented in Figure 3.1. The 25g PE tubing was connected via a stopcock 
to a reservoir filled with AAH and a pressure sensor (Model 26PC, Honeywell, Morristown, 
NJ) which was attached to the exterior cage at the rat’s eye level. The pressure sensor 
was referenced to atmospheric pressure and temperature compensated to eliminate the 
effects of ambient temperature or pressure variations. A custom LabVIEW (National 
Instruments, Austin, TX) program continuously displayed and recorded IOP to a 
computer. A schematic of the tethered perfusion system is presented in Figure 3.2. 
 
18 
3.2.1.2 System Calibration and Characterization 
 The hydrodynamic properties of the perfusion system were characterized prior to 
study commencement. First, the pressure sensor was calibrated against a mercury 
manometer under hydrostatic pressure exertion from a saline reservoir of variable height 
(Ficarrotta et al., 2018). The saline reservoir was connected in parallel to the IOP sensor 
as depicted in Figure 3.2, but the eye was effectively replaced with a mercury manometer. 
The pressure sensor’s gain was adjusted to produce linear (R2 = 0.999) and accurate 
(error = ±0.4 mmHg) readings between 0 and 100 mmHg. 
 System resistance and compliance were measured in the laboratory prior to the 
first animal experiment. The AAH reservoir was replaced by a programmable syringe 
pump (NE-1000; New Era Pump Systems, Farmingdale, NY, USA), and the ocular 
cannula was submerged in a Petri dish filled with saline. Care was taken to ensure the 
opening of the cannula did not rest against the sides or bottom of the dish. Pressure 
responses were recorded for fixed pump rates of 1, 2, 3, 4, and 5 µl/min, and system 
resistance was determined by linear regression of the pressure-flow data. System 
compliance was determined by sealing the opening of polyimide tube and measuring the 
pressure response from bolus injections of saline (1, 2, 3, and 4 µl) into the closed system. 
Compliance was determined by linear regression of the pressure-volume data. 
3.2.1.3 Post-Surgical Care 
 Carprofen (5 mg/kg) was administered subcutaneously for pain relief every 12 
hours for the first 72 hours following surgery. The AAH reservoir remained closed to the 
eye for the first 24 to 48 hours after surgery to allow the animal to recover, then resting 
IOP was established in the implanted eye via the in-line pressure sensor. Resting IOP 
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was consistently established around 6 PM to minimize under- or overestimation of 
average IOP due to circadian rhythms (Bello and Passaglia, 2017); and resting IOP 
defined as the level which IOP fluctuated < 1 mmHg peak-to-peak for 15 minutes. Once 
resting IOP was established, the AAH reservoir was opened to the eye and elevated to 
clamp IOP at 10 mmHg above its resting level. IOP was unilaterally and chronically 
elevated in this manner for durations of approximately 2 weeks, 4 weeks, or 9 weeks. 
Two distinct implanted animal control groups were also created. In one group, the ocular 
cannula was sealed near the skull so that IOP was neither elevated nor clamped. In a 
second group, the AAH reservoir was positioned to clamp IOP at its resting value. 
3.2.2 Tonometry 
 Bilateral tonometry was performed biweekly in some animals to validate IOP 
elevations. Measurements were consistently performed around noontime to minimize the 
influence of circadian fluctuations on IOP readings (Bello and Passaglia, 2017; Moore et 
al., 1996). Animals were anesthetized with 2% isoflurane gas and placed on a heated 
warming pad to maintain body temperature. Ten measurements were performed in each 
eye via a handheld tonometer (Tono-Pen XL, Medtronic, Sarasota, FL) and averaged. 
3.2.3 Fundoscopy 
 Fundus images of control and implanted eyes were acquired in some animals on 
the final day of experiments to assess ocular fluid clarity and general ocular health. 
Animals were anesthetized with 2% isoflurane gas and rested on a heated warming pad. 
A glass coverslip was used to flatten the cornea and a bright light source was positioned 
so the fundus could be viewed under light microscopy. Images were acquired via a digital 
camera fitted to the microscope.  
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3.2.4 Enucleation and Dissection  
 Animals were deeply anesthetized via an intraperitoneal injection of ketamine 
hydrochloride (75 mg/kg) and xylazine (7.5 mg/kg) in preparation for enucleation. Animals 
were transcardially perfused with no less than 120 ml of 10% neutral buffered formalin 
(NBF), until blood visibly cleared from the hepatic vasculature. Both eyes were 
enucleated, with care taken to ensure a remnant of the optic nerve remained intact, and 
submerged in NBF for 30 minutes. The cornea, iris, and lens were excised, and the 
remaining eye structures were submerged in NBF for 48 hours. The retina was then 
isolated from the sclera and transferred to a 24 well plate filled with phosphate-buffered 
saline (PBS) in preparation for immunohistofluorescence, while the remaining sclera and 
attached optic nerve stump were transferred to a microcentrifuge tube filled with PBS for 
separate processing. 
3.2.5 Immunohistofluorescence 
 The following protocol was developed for RGC immunodetection. Retinas were 
permeabilized in 0.5% Triton X-100 in PBS (PBST) for 30 minutes at room temperature, 
washed in fresh 0.5% PBST, and incubated with Brn-3a (C-20) antibody (Santa Cruz 
Biotechnology, Dallas, TX) diluted 1:100 in blocking buffer (2% Triton X-100, 2% donkey 
serum, PBS) for 2 hours at room temperature, then overnight at 4°C. The following day, 
retinas were washed in fresh 2% PBST and 0.5% PBST then incubated with Alexa Fluor 
594 Donkey anti-Goat IgG antibody (Invitrogen, Carlsbad, CA) diluted 1:500 in blocking 
buffer for 2 hours at room temperature. During incubation with the secondary antibody 
and all subsequent processing, well plates were tightly wrapped in aluminum foil to block 
ambient room light. After incubation with the secondary antibody, retinas were washed in 
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2% PBST, 0.5% PBST, then rinsed thoroughly in PBS. Each retina was cut radially 
towards its center at 90-degree intervals (see Figure 3.4), whole-mounted flat onto a 
charged slide, covered with VECTASHIELD® Antifade Mounting Medium (Vector 
Laboratories, Burlingame, CA), and coverslipped. Prepared slides were stored in the dark 
at 4°C until image acquisition.  
3.2.6 Retinal Imaging 
 Whole-mounted retinas were imaged on an Olympus 3i Spinning Disk Confocal 
Microscope with a 10x objective using SlideBook (3i) software. The X, Y, and Z margins 
of the retina were manually determined under light microscopy, and appropriate exposure 
times were automatically determined by the software program. A Z-stack montage image 
of the entire retina was automatically acquired. A maximum intensity projection was 
performed along the Z-axis, and individual image tiles were automatically stitched 
together to generate a single 2D image of the entire retina.  
3.2.7 RGC Counting 
 Image processing and RGC nuclei counting were performed using ImageJ 
software (National Institutes of Health). Raw images were converted to 8-bit grayscale 
images and processed with a custom filter sequence designed to distinguish positively 
stained RGC nuclei. The filter sequence consisted of a convolution filter (kernel size 5 x 
5), an unsharp mask enhancement filter (radius = 2.0 pixels, mask weight = 0.4) and a 
Gaussian blur filter (radius = 1 pixel). The filtered images were then automatically 
thresholded to produce a binary image and overlapping cells were separated by two 
passes of the intrinsic watershed function. Positively stained RGC nuclei were 
automatically counted within area constraints of 15 µm2 to 300 µm2. A visual 
22 
representation of the image processing sequence and RGC counting is shown in Figure 
3.3. The image processing and RGC counting techniques used in this work were modified 
from previous studies (Nadal-Nicolás et al., 2009; Salinas-Navarro et al., 2009). 
3.2.8 Area Density Calculations 
 To assess spatial patterns of RGC loss, RGC area density was calculated for eight 
different regions of each retina. Raw images of each retina were manually segmented 
into four quadrants, following the radial cuts made during the whole-mounting process, 
as shown in Figure 3.4A. Raw images of each retina were also divided into four radial 
regions according to distance from the optic nerve. The average diameter of each retina 
was determined using ImageJ measurement tools and is defined as the average length 
of six lines positioned at 60-degree intervals, extending from edge-to-edge of the retina, 
and passing through the optic nerve. Each retina was segmented into four distinct 
sections according to radial distance from the optic nerve, or radius (R): less than R/4, 
from R/4 to R/2, from R/2 to 3R/4, and greater than 3R/4, as shown in Figure 3.4B. RGC 
number was automatically determined for each quadrant and radial region in ImageJ as 
discussed in section 3.2.7. The area of each quadrant and radial region was determined 
in ImageJ by threshold segmentation and automatic measurement tools. RGC area 
density was calculated for each of the eight sections in each eye and is defined as RGC 
number divided by area. 
3.2.9 Isodensity Maps 
 RGC isodensity maps were created using MATLAB (The MathWorks, Inc., Matick, 
MA) and SigmaPlot (Systat Inc., San Jose, CA) software. RGC coordinates were exported 
from ImageJ, and a custom MATLAB program performed a 2D histogram of positively 
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stained RGCs over grouped pixels. Histogram data was exported to SigmaPlot and 
isodensity maps of each retina were created.  
3.2.10 Optic Nerve Processing and Imaging  
 Optic nerves were processed and sectioned in preparation for light microscopy and 
transmission electron microscopy (TEM). Excess sclera was removed from optic nerve 
tissue. Optic nerves were washed in sodium cacodylate, then in 1% osmium tetroxide for 
one hour, and finally rinsed thrice in sodium cacodylate to remove excess osmium. Optic 
nerves were then dehydrated by washing in a series of graded alcohols: 35% ethanol for 
10 minutes, 50% ethanol for 10 minutes, 70% ethanol overnight, fresh 70% ethanol for 
10 minutes, 95% ethanol for 10 minutes, 100% ethanol for 15 minutes, then 100% 
acetone for 15 minutes. The optic nerves were then infiltrated with resin diluted in acetone 
(2:1 acetone:resin for 30 minutes, 1:1 acetone:resin for 30 minutes, 1:2 acetone:resin for 
30 minutes, then pure resin overnight). Next, optic nerves were washed in fresh pure resin 
for 3 hours, arranged on silicone molds, covered in pure resin, and heated to cure. 
Embedded optic nerves were cut into 90-nm coronal sections and imaged via TEM at 
10,000x, and 350-nm coronal sections for viewing under oil immersion light microscopy 
at 100x. TEM and light microscopy images were qualitatively analyzed. 
3.2.11 Statistical Analysis 
 Paired and unpaired t-tests were performed using SigmaPlot software (Systat Inc., 
San Jose, CA) at an alpha level of 0.05 to assess statistical significance. Results are 
expressed as mean ± standard deviation. 
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3.3 Results 
3.3.1 Perfusion System Characteristics 
 The hydraulic resistance of the perfusion system was 1.024 ± 0.064 (n = 3). This 
matches the theoretical value calculated using Poiseuille’s law and is more than 40-fold 
greater than the resistance of a rat eye (Ficarrotta et al., 2018), so its influence on system 
response dynamics can be ignored. System compliance averaged 0.101 ± 0.025 
μL/mmHg (n = 3), which is similar to that of the rat eye (Ficarrotta et al., 2018, 0.091 ± 
0.018 μL/mmHg, n = 3, p = 0.34). Thus, system tubing does not limit response dynamics. 
3.3.2 Retinal Ganglion Cell Counts 
 IOP was successfully unilaterally elevated by 10 mmHg in 26 animals for durations 
of 10 to 73 days. IOP was continuously measured via the in-line pressure sensor and IOP 
elevations were validated biweekly via tonometry in some animals. A representative IOP 
record and corresponding tonometer measurements are provided in Figure 3.5.  
 RGC number was quantified for both eyes of 12 implanted animals following 
various durations of experimental IOP elevation, and for 5 implanted control group 
animals. The average RGC number for non-implanted eyes was 91,639 ± 3,616 (n = 17). 
RGC number in implanted eyes decreased with increasing duration of IOP elevation. 
RGC number averaged 92,110 ± 4,208 (n = 5), 78,537 ± 2,855 (n = 4), 71,477 ± 1,158 (n 
= 3) and 62,015 ± 2,887 (n = 5) in implanted eyes following IOP elevations lasting 0 days, 
2 weeks, 4 weeks, and 9 weeks, respectively. Figure 3.6 presents total RGC numbers in 
implanted and non-implanted eyes following various durations of IOP elevation. Total 
RGC number was significantly reduced by 2 weeks of IOP elevation and continued to 
decrease with time. RGC number was not significantly different in implanted, non-
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elevated eyes compared to non-implanted eyes (p = 0.81). More specifically, average 
RGC number was not significantly different in non-implanted eyes compared to implanted 
eyes which were not subject to ocular hypertension nor clamping (n = 3, p = 0.63). 
Therefore, the surgical process alone did induce significant RGC death. In implanted eyes 
which were clamped at resting IOP, RGC number averaged 91,719 (n = 2), and each 
RGC number fell within 1.6σ of the non-implanted eye average. This indicates that 
pressure-clamping the eye did not induce RGC death independently. 
 RGC survival fraction is defined as RGC number in the implanted eye divided by 
RGC number in the corresponding non-implanted eye in an individual animal. RGC 
survival fraction averaged 85.7 ± 1.6% (n = 4), 77.5 ± 3.2% (n = 3), and 62.1 ± 4.0% (n = 
5) following 2 weeks, 4 weeks, and 9 weeks of IOP elevations, respectively. RGC survival 
fractions are displayed as a function of duration of IOP elevation in Figure 3.7 for each 
animal. RGC survival fraction decayed exponentially throughout ocular hypertension, and 
was best fit by the equation 
 
SF = yo + ae-bt, 
 
where SF is survival fraction, yo= 0.577 [0.500, 0.650], a = 0.452 [0.379, 0.525], b = 0.036 
[0.021, 0.051] days-1, and t is duration of IOP elevation in days. This 3-parameter 
exponential decay model was selected after evaluating adjusted R2 values for various 
exponential and polynomial models. A residual plot was examined to ensure a lack of 
bias. For the curve fit presented in Figure 3.7, adjusted R2 = 0.949. 
 
26 
3.3.3 Regional RGC Area Densities  
 In 17 animals, RGC area density was calculated for four quadrants and four radial 
sections of each retina. The variation in RGC area density across quadrats of the retina 
was not significantly different in implanted compared to non-impacted eyes following 2 
weeks, 4 weeks, or 9 weeks of IOP elevation (One way ANOVA, p = 0.93), indicating that 
RGCs were not preferentially killed in a specific quadrant of the retina.  
 RGC area density is summarized in Figure 3.8 for various radial regions of the 
retina and durations of IOP elevation. After four weeks of IOP elevation, RGC loss was 
significant only in the outer- and mid-periphery regions; while after 9 weeks, RGC loss 
was significant in all regions of the retina (One way ANOVA, p < 0.001), as can be seen 
in Figure 3.9. 
3.3.4 Fundus Images 
 Representative fundus micrographs from corresponding implanted and non-
implanted eyes are shown in Figure 3.10 following 9 weeks of unilateral IOP elevation. 
Ocular fluids are clear and well-perfused blood vessels can be seen radiating from the 
optic nerve head of both eyes. 
3.3.5 Optic Nerve Cross-Sections  
  Light micrographs of optic nerve cross-sections are shown in Figure 3.11A-C for a 
non-implanted eye, and for implanted eyes following 2 weeks and 9 weeks of IOP 
elevation, respectively. A transmission electron micrograph of the optic nerve from the 
same 9-week implanted animal is shown in Figure 3.11D. After 2 weeks, loss of axon 
density, myelin disruption, and fields of gliosis are apparent, as shown in Figure 3.11B. 
By 9 weeks, extensive axon density reduction, myelin disruption, separation of nerve 
27 
fascicles, and fields of gliosis are evident, as shown in Figure 3.11C; and myelin wrapping 
abnormalities can be clearly seen in Figure 3.11D. The grade of optic nerve injury 
increases with duration of IOP elevation and closely resembles pressure-induced optic 
neuropathies observed in other rat models (Jia et al., 2000; Soto et al., 2011; Chidlow et 
al., 2011). 
3.4 Discussion 
 This study describes the development of a powerful new system with the unique 
ability to precisely prescribe, easily manipulate, and continuously monitor IOP for up to 
73 days in conscious rats. Chronic IOP elevations were achieved by continuous perfusion 
of AAH into the anterior chamber through a gravity-based, tethered perfusion system. 
Whole number and distribution of RGCs were characterized for various durations of 
precise 10 mmHg IOP elevations and optic nerve neuropathies were qualitatively 
assessed. The purpose of this study was to develop a rat glaucoma model which 
overcomes the limitations of existing techniques. Specifically, the constant-pressure 
perfusion (CPP) model does not require multiple interventions or regular tonometry and 
produces IOP elevations which are unparalleled in precision, easily manipulated, and 
stable in time. Moreover, this model does not rely on injuring or altering the conventional 
outflow pathway to induce IOP elevations; therefore, it is suitable for characterizing the 
effects of induced ocular hypertension on C in rats (Chapter 4). 
 IOP elevations of 10 mmHg were deliberately chosen to accurately represent 
ocular hypertension associated with POAG. (Sommer et al., 1991). Furthermore, IOP 
elevations were intentionally limited to one eye of each animal. The contralateral eye thus 
provided a convenient internal control for hypothesis testing. To assess whether this 
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methodology induced optic neuropathy similar to that observed in human glaucoma, RGC 
number and regional variations in RGC area density were quantified; and the appearance 
of the eye, optic nerve, and fundus were examined qualitatively.  
 Brn3a has been identified as a dependable marker of RGC nuclei in both healthy 
and injured retinas (Nadal-Nicolás et al., 2009). Total RGC number was quantified for the 
first time in Brown-Norway rats by Brn3a immunodetection and an automatic cell counting 
routine modified from previous studies (Nadal-Nicolás et al., 2009; Salinas-Navarro et al., 
2009). Total Brn3a positive RGC number averaged 91,639 ± 3,616 for non-implanted 
eyes (n=17). Total Brn3a positive RGC number has been reported as 84,682 ± 7,601 
(Nadal-Nicolás et al., 2009, n=14) and 85,997 ± 3,562 (García-Ayuso et al., 2010, n = 8) 
in adult female Sprague-Dwaley rats, which is an albino strain. The total Brn3a positive 
RGC numbers reported in this study are comparable to but slightly higher than values 
reported in these studies. This discrepancy is likely attributable to differences in animal 
size and strain. Adult female Sprague-Dwaley rats weigh 180–220g (Nadal-Nicolás et al., 
2009), which is about half the weight of rats used in this study; and it has been shown 
that RGC number is significantly higher in pigmented eyes, like the eyes of Brown-Norway 
rats, compared to albino eyes (García-Ayuso et al., 2014; Nadal-Nicolás et al., 2009). 
Total RGC number has been reported as 90,440 ± 2,236 in Pievald Virol Glaxo rats 
(Nadal-Nicolás et al., 2014) and up to 118,860 in adult Wistar rats (n = 1, Laquis et al., 
1998), which are both pigment strains. Thus, rat RGC numbers reported in this 
dissertation are comparable to results from other studies. 
 Both total RGC number and RGC area density decreased with increasing duration 
of IOP elevation. Analysis of the spatial patterns of RGC loss shows that RGCs are not 
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preferentially killed in one quadrant of the retina. Similar results were unanimously 
observed for three distinct rat glaucoma models (Urcola et al., 2006). Non-uniform 
patterns of RGC death are observed across radial regions of the retina, however. RGC 
loss is significant only in the periphery during the first four weeks of IOP elevations, but 
gradually becomes significant in all regions by 9 weeks. Selective RGC death was 
similarly observed in the peripheral retina in episcleral vein cauterization- and 
microsphere occlusion rat glaucoma models (Urcola et al., 2006). In human glaucoma, 
visual field loss initially occurs peripherally (Kolker and Hetherington, 1976), while central 
vision is lost only in advanced stages of the disease. Thus, the patterns of pressure-
induced RGC death observed in this study mimic human glaucoma; and this model will 
be valuable for future studies aimed at better understanding the disease and discovering 
methods to minimize or perhaps, in the future, reverse its progression. 
 No other model can precisely elevate IOP by 10 mmHg in rats; however, some 
studies report similar IOP elevations for similar experiment durations. For example, the 
episcleral vein cauterization model was employed in one study resulting in approximately 
10 mmHg IOP elevations as measured via tonometry (Laquis et al., 1998); and after 10 
weeks, RGC survival was approximately 60%. This dissertation reports 62.09 ± 4.0% 
RGC survival after 9 weeks, and the curve fit to RGC survival data predicts 61.3% survival 
by 10 weeks, which is strikingly similar to RGC survival reported to the previous study. 
The previous study also reports RGC survival fractions of 92% after 2 weeks and 86% 
after 4 weeks, compared to 87.7 ± 1.6% and 77.5 ± 3.2% reported in this dissertation at 
respective times. This dissertation reports greater RGC death during early stages of 
experimental glaucoma, but similar RGC death with increasing time. These discrepancies 
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may be due to the distinct IOP responses induced by various glaucoma induction 
techniques; however, we generally observe extents of RGC death that are comparable to 
other rat glaucoma models. 
 The gravity-based, tethered perfusion system clamps IOP at a level that depends 
on the height of the AAH reservoir relative to the eye. In healthy, conscious rats housed 
under identical light/dark cycles, IOP is not fixed but follows circadian fluctuations of 
approximately 5 mmHg (Bello and Passaglia, 2017). In two animals, an ocular cannula 
was implanted and IOP was clamped at its initial resting level. This was done to test 
whether pressure-clamping the eye induced significant RGC death in the absence of 
ocular hypertension. Average RGC number was virtually identical in eyes clamped at 
resting IOP and non-implanted eyes. Furthermore, RGC number in each of the two control 
animals fell within 1.6σ of the non-implanted eye average. Thus, pressure-clamping the 
eye did not appear to affect RGC number. Similarly, the surgical process did not 
significantly alter RGC number in the absence AAH flow, a result corroborated by lack of 
leakage and foreign body responses due to cannula implantation (Bello et al., 2018). 
These results collectively indicate that the extent of RGC death observed in this 
dissertation is attributable to induced ocular hypertension rather than IOP-clamping or 
surgery.  
 The surgical skill required to successfully implant an ocular cannula is a noteworthy 
limitation of this model. However, with training, the surgical success rate, defined by lack 
of inflammation, infection, and injury, exceeded 90%. Additionally, the tethered perfusion 
system inherently complicates animal handling and is not ideal for behavioral testing. The 
future direction of this project involves replacing the tethered system and AAH reservoir 
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with a wearable micropump, as described in more detail Chapter 6. These modifications 
would simplify the handling of conscious animals and behavioral testing. Chapter 6 further 
describes suggestions for future work related to this project, comprehensively. For 
example, suggestions for inducing IOP elevations which maintain normal circadian 
rhythms, characterizing optic neuropathy at various IOP levels, and utilizing the tethered 
perfusion system to assay prospective neuroprotective treatments are discussed in depth 
in Chapter 6. 
 This study describes a powerful new technique for inducing chronic, unilateral IOP 
elevations in Brown-Norway rats, which result in optic neuropathies mimicking human 
glaucoma. The conventional outflow pathway is spared, and ocular hypertension is 
induced by continuous perfusion of AAH into the anterior chamber for the first time. 
Unrivaled precision in IOP control advances this model’s ability to accurately characterize 
RGC death and optic nerve damage for various durations and degrees of IOP elevation, 
thus advancing current understanding of glaucoma pathogenesis and progression. 
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Figure 3.1 Custom designed coupler. The coupler is affixed to the skull via bone screws 
and reinforced with bone cement. The coupler provides a fixed point of connection 
between the ocular cannula (yellow) and 25g tubing (white). This design prevents excess 
tension on the ocular cannula due to animal motion. 
 
 
Figure 3.2 The tethered perfusion system. This system consists of an ocular cannula, 
AAH reservoir, pressure sensor, and computer. A digital image of a cannulated eye 
immediately following implantation surgery (left) and a schematic diagram of the tethered 
perfusion system (right) are shown. Pressure is exerted via a reservoir filled with AAH, 
which drives fluid into the anterior chamber via the implanted ocular cannula to elevated 
pressure. The pressure sensor continuously displays and records IOP to a computer. This 
system is capable of prescribing, manipulating, and continuously monitoring IOP in rats. 
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Figure 3.3 Image processing and RGC counting. A visual representation of the image 
processing sequence and automatic RGC counting are shown. (A) A maximum z-
projection image of a single mosaic tile of the raw retina image. (B) Image A following the 
application of the custom filter sequence for distinguishing RGCs. (C) Image B auto-
thresholded to produce a binary image and following two passes of the watershed 
function which differentiates overlapping cells. (D) Image C overlaid with masks indicating 
counted RGC nuclei within area constraints. 
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Figure 3.4 Schematic of retinal segmentation. Each retina was segmented into the 
eight sections collectively depicted here for RGC area density analyses. Retinas were 
segmented along red rings in image A for comparison of RGC area density as a function 
of radial distance from the optic nerve. Retinas were also segmented along red lines in B 
for comparison of RCG area density in various quadrants. 
 
 
Figure 3.5 IOP records. (A) Representative IOP record from corresponding implanted 
and control eyes throughout 63 days unilateral IOP elevation. Each data point is the 
average of 10 tonometer readings. The response from the in-line IOP sensor is also 
shown for the implanted eye. (B) Image of the implanted eye after 63 days of IOP 
elevation. The ocular cannula in visible in the medial aspect of eye, yet the eye appears 
healthy otherwise.  
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Figure 3.6 RGC counts. (A) Average RGC number in implanted and non-implanted eyes 
following various durations of unilateral IOP elevation by 10 mmHg. The 0 days implanted 
eye group represents animals implanted in one eye for 9 weeks without IOP elevation. 
Error bars represent standard deviations. Double and single asterisks represent 
statistically significant differences (p < 0.001, p < 0.05, respectively).  
 
 
36 
 
 
Figure 3.7 RGC survival fractions. For each implanted animal, RGC survival fraction 
represents the total RGC number in the non-implanted eye divided by RGC number in 
the corresponding implanted eye. Survival fraction plotted against duration of IOP 
elevation can be accurately fit by a 3-parameter exponential decay function (adjusted R2 
= 0.949). 
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Figure 3.8 Normalized RGC area densities. Average RGC area densities were 
normalized to the non-implanted eye average for each radial section and duration of IOP 
elevation. RGCs in the outer-and mid-periphery regions were preferentially killed during 
the first 4 weeks of IOP elevations. By 9 weeks, RGC death was significant across all 
retinal regions. Error bars represent standard deviation. 
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Figure 3.9 RGC isodensity maps. Representative RGC isodensity maps showing the 
spatial distribution of Brn3a positive RGC nuclei in a non-implanted control eye retina (A) 
and an implanted eye retina following 9 weeks of IOP elevation (B). RGC loss appears 
uniform across the entire retina, supporting results from RGC area density analyses. Bin 
size is approximately 370 x 370 µm. 
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Figure 3.10 Fundus micrographs. Light micrographs of the fundus of a representative 
control eye (A) and implanted eye following 9 weeks of unilateral IOP elevation by 10 
mmHg (B). Ocular fluids are clear and well-perfused retinal blood vessels can be seen 
radiating from of the optic nerve head of each eye.  
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Figure 3.11 Micrographs of optic nerve cross-sections. Light micrographs of healthy 
optic nerves (A) and glaucomatous optic nerves following 2 weeks (B) and 9 weeks (C) 
of 10 mmHg IOP elevation. Axon density reduction, myelin disruption, and fields of gliosis 
are apparent at 2 weeks and become visibly more severe by 9 weeks. (D) Myelin 
wrapping abnormalities are evident in a transmission electron micrograph of the optic 
nerve following 9 weeks of 10 mmHg IOP elevation. 
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Chapter 4: The Effect of Experimental Glaucoma on Aqueous Humor Dynamics in 
Rats 
 
4.1 Introduction 
Chapter 3 presented a novel method for inducing chronic ocular hypertension and 
assessed the resulting anatomical effects. By contrast, this chapter describes the effects 
of chronic constant-pressure perfusions on eye physiology: specifically, C and resting 
IOP. While previous studies have investigated patterns of RGC loss for various animal 
glaucoma models, no study to date has characterized the effects of experimental 
glaucoma on C in living animals. Because most rat glaucoma models rely on altering the 
trabecular meshwork or its vasculature to induce ocular hypertension, studying causal 
effects of elevated IOP on the trabecular meshwork was not previously meaningful in 
these models. The CPP model spares the trabecular meshwork, offers continuous IOP 
records, and provides direct access to the anterior chamber for perfusion and C 
measurements. Therefore, the CPP model is well-suited to study the effects of induced 
ocular hypertension on otherwise healthy trabecular for the first time in a meaningful way. 
Outflow facility has not previously been characterized in living animals throughout 
experimental glaucoma; however, several ex-vivo and cultured eye experiments have 
investigated the effect of elevated IOP on C. Outflow resistance reportedly varies in 
response to elevated IOP in perfused anterior segment organ cultures and ex-vivo eyes 
(Acott and Kelley, 2008; Borras et al., 2002; Bradley et al., 2001; Keller et al., 2009a; 
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Hashimoto and Epstein, 1980). Some studies suggest the continued exposure of 
trabecular meshwork cells to elevated IOP increases C, perhaps to maintain homeostatic 
IOP, while other studies suggest elevated IOP increases the rigidity of the trabecular 
meshwork and thus reduces C (Gabelt and Kaufman, 2005; Schlunck et al., 2008). By 
contrast, some studies in ex-vivo eyes report that IOP elevations do not significantly affect 
outflow facility (Millar et al., 2011; Lei et al., 2011; Hashimoto and Epstein, 1980). In either 
case, the aforementioned studies were limited to ex-vivo eyes or cultured anterior 
segments and experimental durations were limited as a result. Cultured anterior 
segments deteriorate significantly over time (Keller et al., 2013) and ex vivo eyes are 
similarly subject to necrosis. 
Evidently, the mechanisms of IOP-induced outflow facility accommodation remain 
controversial and require further investigation, ideally in living animals. While genetic and 
possibly environmental factors contribute to glaucoma pathogenesis, impaired IOP 
homeostatic capability is paradigm to disease progression. Furthermore, approximately 
25% of new cases of blindness are attributable to glaucoma; therefore, understanding the 
regulation of both normal (Chapter 2) and glaucomatous aqueous outflow resistance is of 
significant medical importance (Quigley, 1993, Quigley, 1996, Quigley and Vitale, 1997). 
The goal of this chapter is to characterize C and resting IOP in living animals throughout 
the CPP model of experimental glaucoma in rats. 
4.2 Methods 
The following experiments were performed in accordance with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research and in compliance 
with a protocol approved by the Institutional Animal Care and Use Committee at the 
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University of South Florida. All experiments were performed on adult male retired-breeder 
Brown-Norway rats (300-400 g) housed under a 12:12 light-dark cycle with free access 
to food and water 
4.2.1 Experimental Setup 
Cannula implantation surgeries were performed for 19 rats following Chapter 3 
methodology. Ocular hypertension was induced via the CPP model in 17 animals for 
durations of 14 to 73 days, and the remaining 2 animals served as implanted controls with 
IOP clamped at its resting level (65 days, 64 days). Resting IOP was established in the 
implanted eye of conscious animals via the tethered perfusion system prior to elevating 
IOP and on the final day of each experiment.  
4.2.2 Terminal Experiments 
On the final day of each experiment, resting IOP and C were measured in both the 
implanted and non-implanted eye via the perfusion system described in Chapter 2. This 
system is reintroduced in Figure 4.1. Anesthesia was induced in each animal via an 
intraperitoneal injection of ketamine hydrochloride (75 mg/kg) and xylazine (7.5 mg/kg) 
and maintained through intravenous delivery of ketamine (30 mg/kg/h). Animals were 
placed on a warming pad to maintain body temperature and mounted in a stereotaxic 
apparatus. Heart rate and body temperature were monitored and maintained at 
physiological levels by anesthetic infusion rate adjustments. An incision was made at the 
scalp to expose the ocular cannula; then the cannula was cut and sealed with glue to 
prevent AAH flow. One drop of cyclopentolate hydrochloride (1%) was instilled in each 
eye to dilate the pupil, then the eye was obliquely cannulated with a 33g hypodermic 
needle (TSK Laboratory, Tochigi, Japan, length: 13 mm, lumen: 0.11 mm) connected via 
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25g tubing to a programmable syringe pump (NE-1000; New Era Pump Systems, 
Farmingdale, NY, USA) and calibrated pressure sensor (Ficarrotta et al., 2018). Corneas 
were covered with a clear contact lens and saline drops were instilled in each eye every 
10-15 minutes. The cannulated eye was frequently examined under light microscopy for 
internal tissue damage and visible fluid leakage. Resting IOP was established and C was 
measured via the mCP technique (Ficarrotta et al., 2018) in the implanted and non-
implanted eye, independently. A control algorithm switched the AAH pump on and off to 
hold IOP within 2 mmHg of a user-defined level. Net outflow (F) was calculated for each 
pump cycle at each IOP set point as the product of pump inflow rate (Fp), which was fixed 
at 1.5 µL/min, and the measured pump duty cycle. F data were averaged for each 
pressure level and linearly regressed against IOP to estimate C. Resting IOP and C 
measurements were not routinely initiated in a particular eye but alternated between 
animal experiments; and each eye was cannulated with a new 33g needle.  
4.2.3 Serial Measurements 
Resting IOP and C were recurrently measured throughout experimental glaucoma 
in five animals. The tethered perfusion system was modified to facilitate periodic, serial 
measurements of C. The AAH reservoir was temporarily replaced by a programmable 
syringe pump (NE-1000; New Era Pump Systems, Farmingdale, NY, USA) and a custom 
LabView program (National Instruments, Austin, TX, USA) controlled pump activity and 
displayed and recorded IOP to a computer (Ficarrotta et al., 2018). The modified tethered 
perfusion system is depicted in Figure 4.2. Each of the five animals endured chronic, 
experimental IOP elevations of 10 mmHg, as described in Chapter 3, for durations of 27 
to 73 days. Resting IOP was established and C was measured via the previously 
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described mCP perfusion technique (Ficarrotta 2018) at 1 to 3 week intervals in each 
animal. During serial experiments, animals were anesthetized with 2% isoflurane and 
rested on a warming pad to maintain normal body temperature, but no additional 
treatments were administered. After data collection, animals remained on the warming 
pad until deliberate ambulatory movements were apparent. The AAH reservoir was then 
reconnected to replace the syringe pump, and IOP was elevated by 10 mmHg until the 
next serial outflow experiment.  
4.2.4 Outflow Measurement in a Conscious Rat 
The feasibility of measuring C in conscious animals was also investigated. In one 
distinct animal, C was measured two days after cannula implantation surgery via the CF 
perfusion technique and modified tethered perfusion system. IOP was not elevated prior 
to nor after C measurement in this animal. Equilibrium IOP was determined for pump 
rates of 0.0, 0.1, 0.2, 0.3, 0.4, and 0.5 µl/min in the conscious animal, and C was 
estimated by regression analysis of the pressure-flow data (Ficarrotta et al., 2018). 
4.2.5 Histologic Processing 
The impact of experimental glaucoma on the iridocorneal angle was histologically 
examined in 7 rats. Following data collection, deeply anesthetized animals were 
transcardially perfused with NBF, then eyes were enucleated and submerged in NBF for 
24 hours. Each eye was embedded in paraffin, sliced in 4-μm sections, and mounted on 
gelatin-coated slides. Iridocorneal angle sections were stained with hematoxylin and 
eosin, viewed under light microscopy, and digitally photographed.  
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4.2.6 Data Analysis 
Statistical significance was assessed via paired and unpaired t-tests at an α level 
of 0.05 using SigmaPlot software (Systat, Inc., San Jose, CA, USA), unless otherwise 
indicated. Results are expressed across experiments as mean ± standard deviation (SD) 
and within experiments as 95% confidence intervals in brackets.  
4.3 Results 
 The hydrodynamic properties of the tethered perfusion system were described in 
Chapter 3. System characteristics, namely resistance and compliance, were found to not 
limit response dynamics. Resting IOP was not significantly affected by chronic IOP 
elevations but returned to its original resting value in the absence of hydrostatic pressure 
exertion. Resting IOP respectively averaged 15.59 ± 1.58 mmHg and 15.82 ± 1.49 mmHg 
on the initial and final days of IOP elevation experiments, as measured through the 
tethered perfusion system in the implanted eye of conscious animals (n = 17, p = 0.51). 
Intra-eye IOP shifts are presented as a function of duration of IOP elevation for each 
animal in Figure 4.3. IOP shift and duration of IOP elevation are not significantly related 
(Pearson Product Moment Correlation, n = 19, p = 0.29). 
Similarly, resting IOP was not significantly different in implanted and non-implanted 
eyes at the conclusion of each experiment, as measured via a 33g needle in ketamine 
anesthetized animals. Resting IOP averaged 15.40 ± 1.06 mmHg in implanted, perfused 
eyes and 15.15 ± 1.13 mmHg in non-implanted eyes during terminal experiments (n = 17, 
p = 0.24). Inter-eye IOP differences are shown as a function of duration of IOP elevation 
for each animal in Figure 4.4. Inter-eye IOP difference and duration of IOP elevation are 
related (Pearson Product Moment Correlation, n = 19, p = 0.59). 
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C averaged 0.0235 ± 0.0015 µl/min/mmHg in implanted eyes and 0.0241 ± 0.0028 
µl/min/mmHg in non-implanted eyes of ketamine anesthetized animals at the termination 
of IOP elevation experiments (n=17, p = 0.36). The inter-eye differences in C as a function 
of duration of IOP elevation are plotted in Figure 4.5 for each animal. These variables are 
not significantly related (Pearson Product Moment Correlation, n = 19, p = 0.29). 
Furthermore, the inter-eye difference in C was significant in only 1 of 17 individual animals 
(ANCOVA Homogeneity of Regressions, F < 3.39, p > 0.103 for 16 of 17 comparisons).  
Neither resting IOP nor C significantly varied in individual animals throughout 
experimental glaucoma, despite significant RGC loss and the development of 
glaucomatous pathology. Figure 4.6 plots resting IOP and C in time for the five animals 
involved in serial outflow experiments. The corresponding RGC survival fraction and 
experiment duration are provided for each animal. Neither IOP nor C are significantly 
related to time in any individual animal (Pearson Product Moment Correlation, p > 0.14, 
p > 0.39, respectively). Furthermore, C and resting IOP were indistinguishable between 
the two perfusion systems (n = 5, p > 0.35 for both comparisons). 
C was measured via the CF perfusion technique in one conscious animal. The 
pressure-flow data from this experiment is presented in Figure 4.7, where linear 
regression estimates C as 0.0252 [0.0231, 0.0273]. In healthy eyes, C averaged 0.0235 
± 0.0015. Hence, C in the conscious animal is within approximately 1σ of the average 
value of C in healthy eyes, seemingly indicating that C can be accurately measured in 
conscious animals via the modified tethered perfusion system. 
The iridocorneal angle of implanted, chronically perfused eyes appeared normal 
under light microscopy at the conclusion of chronic IOP elevation experiments. Figure 4.8 
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shows that the trabecular meshwork of implanted eyes was morphologically intact and 
the iridocorneal angle appeared similar to that of the non-implanted eye, consistent with 
the lack of evidence for significant changes in C or resting IOP. 
4.4 Discussion 
This study characterized C and resting IOP in glaucomatous Brown-Norway rats. 
Glaucoma was experimentally induced via continuous constant-pressure perfusion of 
AAH into one eye of conscious animals for durations of 0 to 73 days. Non-implanted eyes 
served as convenient internal controls for hypothesis testing at the conclusion of 
experimental glaucoma, while serial measurements were performed in implanted eyes to 
assess intra-eye variability throughout several experiments. Resting IOP and C were 
stable in implanted eyes during experimental glaucoma and were not significantly 
different in implanted and non-implanted eyes during terminal experiments. The 
iridocorneal angle appeared normal at the conclusion even the longest IOP elevation 
experiment, corroborating the lack of evidence for altered aqueous humor dynamics. 
Moreover, C was successfully measured in a conscious animal through the modified 
tethered perfusion system, indicating that serial measurements in conscious animals are 
feasible under this methodology.  
Various studies report conflicting results regarding the effect, or lack of effect, of 
experimental IOP elevations on resting IOP and C (Hashimoto and Epstein 1980; 
Ellingsen and Grant, 1971; Acott and Kelley, 2008; Borras et al., 2002; Bradley et al., 
2001; Keller et al., 2009a; Millar et al., 2011; Lei et al., 2011; Stamer et al., 2011; 
Schneemann et al., 2003). Our results indicate that chronic 10 mmHg IOP elevations, 
induced by the CPP model, do not significantly or permanently alter the function of the 
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conventional outflow pathway or resting IOP, despite inducing optic neuropathies 
characteristic of glaucoma. One study involving human cell cultured anterior chambers 
reports that prolonged IOP elevations significantly increase C between day 1 and day 4, 
but the effect disappears with increasing experiment duration (Borras et al., 2002). In this 
study, the first serial experiments are performed 7 days after the initiation of ocular 
hypertension. Therefore, it is possible that C and resting IOP were modulated between 
day 0 and day 7, but the effect is no longer detectable by the first serial experiments. 
Future studies aimed at continuously measuring C within the first week of IOP elevations 
and beyond appear to be worthwhile. Suggestion for future experiments designed to 
achieve this goal, and additional recommendations for future work related to this project, 
are provided in detail in Chapter 6.  
The ability to measure C in conscious animals is a significant achievement of this 
work. Classically, aqueous humor dynamics have been quantified in cultured anterior 
chamber segments or intact ex-vivo eyes. Several studies have recently assessed 
aqueous humor dynamics quantitatively in anesthetized animals, which introduces 
logistical challenges but perhaps better represents normal animal physiology. This study 
is the first to report C in a conscious animal without any treatments, which is ideal for 
quantitative assessment of physiological parameters. Several conscious animal 
experiments have been suggested in Chapter 6 to advance our understanding of aqueous 
humor dynamics in both healthy and glaucomatous eyes, and to ascertain how closely 
the aqueous outflow characteristics of rat eyes may resemble those of human eyes.  
It is beyond the scope of this study to conclude whether trabecular meshwork 
changes are occurring at a cellular level throughout experimental glaucoma. Perhaps 
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trabecular meshwork stiffening and washout effects are balanced such that changes in C 
are not measurable, for example. We can say with confidence, however, that resting IOP 
and C are not permanently altered throughout 7 to 73 days of 10 mmHg IOP elevations 
imparted via the CPP model of experimental glaucoma.  
This chapter describes a technique for accurately tracking conventional outflow 
function throughout experimental glaucoma. This is the first study to investigate the 
effects of chronic IOP elevations on aqueous humor dynamics in living animals, and the 
first study to perform serial outflow measurements in the same animal over a duration of 
many weeks. Outflow measurements in conscious animals were found to be feasible, 
indicating that the modified tethered perfusion system may be able to facilitate serial 
measurements of C in conscious animals in future studies. 
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Figure 4.1 Ocular perfusion system. A schematic diagram of perfusion system used to 
assess aqueous humor dynamics in terminal animal experiments.  
 
 
Figure 4.2 Modified tethered perfusion system. A schematic diagram of the modified 
tethered perfusion system used to serially assess aqueous humor dynamics throughout 
experimental glaucoma. 
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Figure 4.3 Resting IOP shifts in implanted eyes. Intra-eye resting IOP shifts are shown 
for implanted-eyes of individual animals following various durations of IOP elevation by 
10 mmHg. 
 
 
Figure 4.4 Inter-eye IOP differences during terminal experiments. The difference 
between IOP in non-implanted eyes and fellow implanted, perfused eyes for individual 
animals following various durations of IOP elevation. 
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Figure 4.5 Inter-eye C differences during terminal experiments. The difference 
between C in non-implanted eyes and fellow implanted, perfused eyes following various 
durations of IOP elevation in individual animals. 
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Figure 4.6 Serial measurements of resting IOP and C. Serial measurements of C (A) 
and resting IOP (B) throughout experimental glaucoma for 5 rats. Error bars represent 
standard error on C estimates from least squares regression analysis (A) and standard 
deviation of mean resting IOP (B). 
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Figure 4.7 Light micrographs of the iridocorneal angle. Hematoxylin and eosin 
stained thin (4 µm) sections of the iridocorneal angle of a non-implanted eye (left) and an 
implanted, perfused eye (right) following 9 weeks of chronic constant-pressure perfusion. 
The trabecular meshwork and Schlemm’s canal of the implanted, perfused eye appear 
morphologically intact and similar to the non-implanted eye. TM, trabecular meshwork; 
SC, Schlemm’s canal. 
 
 
Figure 4.8 C in a conscious animal. Pressure-flow data from a CF experiment in the 
eye of a conscious rat. For this animal, C was 0.025 [0.023, 0.027] and the y-intercept = 
-0.424 [0.394, 0.453]. The line is a linear regression fit of the data. Error bars represent 
standard deviation. 
IOP (mmHg)
10 15 20 25 30 35 40
F
 (
l/
m
in
/m
m
H
g
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
56 
 
 
 
 
 
Chapter 5: The Effect of Intracranial Pressure Elevation on Aqueous Humor 
Dynamics in Rats 
 
5.1 Note to Reader 
 A modified version of this chapter will be submitted to the Proceedings of the 
National Academy of Sciences of the United States of America (PNAS) near the time this 
dissertation is submitted to the University of South Florida. 
5.2 Introduction 
 Conclusive evidence of a causal relationship between elevated IOP and the onset 
and progression of glaucomatous RGC damage remains controversial (J. Crawford 
Downs et al., 2008). Current evidence suggests IOP-induced stress and strain on the 
optic nerve head ultimately kills RGCs (Minckler et al., 1977; Quigley and Anderson, 
1976; Minckler, 1986; Quigley and Anderson 1977); yet there are several conditions 
which cannot be explained by this straightforward model. For example, glaucomatous 
damage is observed even in the absence of elevated IOP in patients with NTG. NTG is a 
prevalent form of the disease which can account for 30-92% of all glaucoma diagnoses 
depending on race and ethnicity (Cho and Key, 2014). Furthermore, a significant 
proportion of patients with ocular hypertension never develop glaucoma (Kass et al., 
2002; Weinreb and Khaw, 2004). In these patients, elevated IOP is not accompanied by 
visual field loss or characteristic pathological manifestations typically observed at the 
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optic nerve head. Evidentially, elevated IOP is not a definitive indicator for whether 
glaucoma will develop and there may be other important risk factors to investigate.  
One potential explanation for NTG and ocular hypertension is cerebral spinal fluid 
(CSF) theory (Berdahl and Allingham, 2010). CSF fills the ventricles of the brain and 
surrounds the brain, spinal cord, and optic nerve to form a continuous fluid-filled 
compartment of nearly uniform pressure (Lenfeldt et al., 2007). Therefore, pressure 
immediately posterior to the eye is determined by cerebrospinal fluid pressure (CSFP); 
and CSFP and ICP are approximately equivalent and used interchangeably in medical 
practice and literature (Chowdhury and Fautsch 2015; Lenfeldt et al., 2004; Berdahl and 
Allingham 2010; Berdhal et al., 2008b; Morgan et al., 1995). According to CSF theory, the 
stress felt at the optic nerve head is determined by the difference between IOP and CSFP, 
or the translaminar pressure difference (TLPD), rather than IOP alone (Berdahl and 
Allingham, 2010). This theory suggests that depressed ICP may have the same effect on 
the optic nerve head as elevated IOP; and elevated ICP may mimic the effects of 
depressed IOP. Figure 5.1 illustrates CSF theory and relative magnitudes of ICP and IOP 
for a healthy eye, glaucomatous eyes, and a hypertensive eye. 
There is strong evidence which supports CSF theory and implicates reduced ICP 
as a significant risk factor for glaucoma. For example, retrospective clinical studies have 
shown a correlation between depressed ICP and glaucoma: POAG and, most 
significantly, NTG (Berdahl et al., 2008a; Berdahl et al., 2008b; Chen et al., 2015). As 
illustrated in Figure 5.1, significantly depressed ICP generates an aberrant TLPD and is 
expected to result in glaucomatous damage according to CSF theory. Some of the same 
studies also report that ICP is significantly elevated in patients with ocular hypertension 
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who never develop glaucoma (Berdahl et al., 2008a; Berdahl et al., 2008b). As 
demonstrated in Figure 5.1, if both IOP and ICP are elevated, a homeostatic TLPD can 
be maintained.  
Furthermore, several experimental animal studies support CSF theory. One study 
showed that reducing ICP via implantation of a ventriculoperitoneal shunt induces 
glaucoma-like pathology in non-human primates (Yang et al., 2014). A similar study in 
rats showed that chronically reducing ICP resulted in significant RGC death and reduced 
optic nerve axon density (Chowdhury et al., 2016 ARVO abstract). In mice, chronically 
elevating rather than lowering ICP also resulted in significant RGC death (Nusbaum et 
al., 2015). Furthermore, it has been reported that the TLPD affects optic disc 
displacement, cup depth, and the ERG (Morgan et al., 2002; Zhao et al., 2015). The 
relationship between IOP and ICP has also been investigated. One study induced 
experimental ICP elevations in monkeys and reported a subsequent increase in IOP 
within minutes (Lehman et al., 1972). Similarly, lowering ICP in dogs initiated a parallel 
reduction in IOP such that the trans-lamina cribrosa gradient (TLPG) remained stable 
(Hou et al., 2016).  
Despite this evidence, the relationship between IOP and ICP and the mechanisms 
of TLPD regulation are still not well-understood. Furthermore, the effect of ICP on 
aqueous humor dynamics rather than IOP alone has not been considered in prior studies. 
The purpose of this study was to investigate the effects of experimental ICP elevations 
on C in rats. 
 
 
59 
5.3 Methods 
 All experiments were conducted in accordance with the ARVO Statement for the 
Use of Animals in Ophthalmic and Vision Research and in compliance with a protocol 
approved by the Institutional Animal Care and Use Committee at the University of South 
Florida. 
5.3.1 Experimental Setup 
 Male retired-breeder Brown-Norway rats (300-400 g) were housed under a 12:12 
light-dark cycle with free access to food and water. On the day experimentation, animals 
were anesthetized with an intraperitoneal injection of ketamine hydrochloride (75 mg/kg) 
and xylazine (7.5 mg/kg), supplemented as needed. Anesthesia was maintained by 
intravenous delivery of ketamine (30 mg/kg/hr) through a catheter inserted in the femoral 
vein. Body temperature, heart rate, and mean arterial pressure (MAP) were monitored 
and kept at physiological levels by adjusting anesthetic infusion rate. Body temperature 
was recorded with a rectal thermometer and controlled with a heating pad. Heart rate was 
recorded with ECG electrodes. MAP was recorded with a pressure sensor connected to 
a saline-filled catheter inserted in the femoral artery. The animal was then positioned in a 
stereotaxic instrument, an incision was made in the scalp, and a 0.5-mm hole was drilled 
in the skull 1-mm caudal and 1.5-mm lateral to Bregma. A 25g needle connected to a 
micromanipulator was advanced approximately 3.5-mm through the hole into a cerebral 
ventricle. The needle was connected via a 3-way stopcock and polyethylene tubing 
(length: 45 cm, lumen: 0.4 mm) to a pressure sensor and a reservoir of physiological 
saline mixed with 1% green vital dye (Davidson Marking System, Middleton, WI). After 
ventricle cannulation, indicated by a jump in pressure reading, the needle was fixed in 
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place and the hole sealed with dental cement (A-M Systems, Sequim, WA). Successful 
cannulation was verified by stabilization of ICP at >3 mmHg and by post-experimental 
assessment of dye location. Pupils of both eyes were dilated with 1% cyclopentolate 
hydrochloride drops, and the anterior chamber of one eye was cannulated with a 33g 
needle connected via a 3-way stopcock and polyethylene tubing (length: 45 cm, lumen: 
0.4 mm) to a pressor sensor and a programmable syringe pump (NE-1000, New Era 
Pump Systems, Farmingdale, NY) filled with artificial aqueous humor (AAH). Corneas 
were covered with clear contact lenses and moistened every 10-15 minutes with saline 
drops. The cannulation site was repeatedly checked to confirm there was no needle 
displacement, internal tissue damage, or visible fluid leakage.  
 Figure 5.2 illustrates the experimental setup. Each pressure sensor (Model 26PC, 
Honeywell, Morristown, NJ) was calibrated against a mercury manometer prior to data 
collection. The calibration procedure and the hydrodynamic properties of the perfusion 
system have been described (Ficarrotta et al., 2018). Sensor outputs were amplified, low-
pass filtered at 1 Hz, and digitized at 2 Hz to a computer by a custom LabView (National 
Instruments, Austin, TX) program. Data collection began when ICP and IOP settled at 
values that fluctuated <1 mmHg over 15 minutes. These values were defined as the 
resting ICP and IOP. 
5.3.2 Data Collection 
 C was measured via the mCP technique. A control algorithm switched the AAH 
pump on and off to maintain IOP within 2 mmHg of a user-specified level (Ficarrotta 2018). 
F was calculated for different IOP set points as the product of Fp, which was fixed at 1.5 
µL/min, and the measured pump duty cycle. F data were averaged over 4-6 pump cycles 
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for each set point and linearly regressed against IOP to estimate C. C was measured at 
resting ICP and at ICP set 15 mmHg above the resting level. In some experiments, C was 
also measured for 5mmHg steps in ICP up to 15mmHg (linearity), or after returning ICP 
to its resting level (reproducibility). In a distinct subset of experiments, C was remeasured 
at elevated ICP after topical application of tetrodotoxin (TTX, 1 µg/µl in saline), or after 
animal euthanasia. ICP was manipulated by varying reservoir height. Pressure-flow data 
were collected >30 minutes after height changes when ICP had stabilized at the target 
level. Statistical significance was assessed with paired and unpaired t-tests at an alpha 
level of 0.05 using SigmaPlot software (Systat Inc., San Jose, CA), unless otherwise 
indicated. Individual animal results are expressed as 95% confidence intervals in 
brackets, while across-animals results are expressed as mean ± standard deviation (SD). 
5.3.3 Histological Processing  
 After animal euthanasia, the dye-perfused brain was excised and submerged in 
10% neutral buffered formalin (NBF) for 24-48 hours. Fixed brains were embedded in 
paraffin, sliced in 4-µm coronal sections, and mounted on gelatin-coated slides. Tissue 
sections were stained with hematoxylin and eosin, viewed under light microscopy, and 
digitally photographed. 
5.4 Results 
 Cerebral ventricle cannulation was validated by histological examination of the 
dye-perfused brain. Figure 5.3 shows that dye molecules were located in multiple 
disparate areas of the lateral ventricles but not in surrounding tissues of these or other 
brain sections, indicating that the ventricle was successfully cannulated in this 
experiment. The result was the same for every brain examined (n = 8).  
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 Figure 5.4 shows representative IOP, ICP, and MAP data collected from an 
anesthetized rat. C was estimated by determining the pump duty cycle required to hold 
IOP at different levels. It can be seen that pump-driven cyclic and sustained changes in 
IOP had no discernable effect on ICP and MAP. Resting ICP averaged 5.8 ± 2.0 mmHg 
(n = 15) and MAP averaged 97 ± 4 mmHg (n = 3). These values were not significantly 
different at peak IOP elevation (p = 0.62 and 0.28, respectively). After estimating outflow 
facility at resting ICP, ICP was increased by 15 mmHg and facility measurements were 
repeated. ICP elevation had no discernable effect on MAP either (p = 0.55). There was a 
small but significant increase in resting IOP of 1.9 ± 1.4 mmHg across animals after ICP 
elevation (p < 0.001). 
 ICP changes had a marked effect on aqueous humor dynamics. Figure 5.5A shows 
pressure-flow data of a rat eye at resting and elevated ICP. C was reduced at elevated 
ICP, as evidenced by the decrease in slope of the data from 0.020 to 0.011 µl/min/mmHg. 
Figure 5.5B summarizes outflow facility measurements across animals for an ICP 
elevation of 15 mmHg (n = 15). C averaged 0.021 ± 0.004 µl/min/mmHg at resting ICP, 
which is indistinguishable from prior measurements in rats not subjected to cerebral 
ventricle cannulation (p = 0.68) (Ficarrotta et al., 2018). At elevated ICP, C averaged 
0.0127 ± 0.0036 µl/min/mmHg, a reduction of 41.0 ± 13.4%. ICP was subsequently reset 
to the resting level in two experiments. Figure 5.6 shows pressure-flow data of a rat eye 
before, during, and after ICP elevation. It can be seen that the slope returned to near-
baseline level when resting ICP was restored, indicating that the change in outflow facility 
was reversible. The resting IOP did not return to the baseline level in this animal, which 
may reflect natural variability or circadian IOP rhythms since data collection lasted several 
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hours. C post-ICP elevation was within 1.1σ of average C pre-ICP elevation for both 
experiments. The difference between pre- and post-ICP elevation slope was not 
significant in either experiment (ANCOVA Homogeneity of Regressions, F < 0.46, p > 
0.523 for both comparisons). 
 The effect of ICP on C was graded in magnitude. Figure 5.7A shows pressure-flow 
data of a rat eye in which intermediate ICP levels were also tested. C decreased 
systematically with ICP elevation from 0.020 to 0.011 µl/min/mmHg. Figure 5.7B shows 
the relationship was approximately linear for the range tested. The resting IOP also 
shifted progressively higher in this animal with ICP elevation due presumably to the 
decreasing outflow facility. This experiment was performed twice, with an apparent linear 
relationship between C and ICP elevation each time (R2 = 0.991, 0.990). 
 Measurements were repeated on dead eyes at elevated ICP. Figure 5.8 shows 
pressure-flow data of a rat eye at resting ICP, elevated ICP, and elevated ICP after animal 
euthanasia. The dead-eye data are shifted leftward since there is no aqueous production 
to maintain the resting IOP. It can be seen that C decreased after ICP elevation but 
returned to near-baseline level after euthanasia even though ICP remained high. C at 
elevated ICP was 0.019 ± 0.004 µl/min/mmHg across experiments on dead eyes (n = 9). 
This is greater than C at elevated ICP (0.013 ± 0.04 µl/min/mmHg, p < 0.001) and not 
different from C at resting ICP (0.022 ± 0.003 µl/min/mmHg, p = 0.07) when those eyes 
were alive. The effect of ICP on C thus appears to have a physiological origin. 
 To determine whether neural signaling pathways might be involved, TTX was 
applied to the cornea of the eye. Figure 5.9A shows pressure-flow data of a rat eye at 
resting ICP, elevated ICP, and elevated ICP after TTX application. The voltage-gated 
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sodium-channel blocker partially or completely eliminated ICP-dependent changes in 
outflow facility for every animal tested (n = 4). C at resting ICP and elevated ICP was 
0.023 ± 0.002 and 0.013 ± 0.003 µl/min/mmHg, respectively. After drug application, C at 
elevated ICP was .021 ± .007 nl/min/mmHg, which is larger than the pre-TTX level (p < 
0.05) and not different from the baseline level (p = 0.63). Figure 5.9C shows that TTX had 
no detectable impact on outflow facility at resting ICP. C before and after drug application 
averaged .025 ± 0.002 and 0.024 ± 0.003 µl/min/mm, respectively (n = 3, p = 0.46). 
5.5 Discussion 
 This study quantified C in anesthetized rats under varying levels of experimental 
ICP elevation. C was found to decrease and IOP was observed to increase subtlety with 
ICP elevations of 15 mmHg. The effect of ICP on IOP is consistent with several prior 
studies which report a correlation between the two pressure quantities (Lehman et al., 
1972; Hou et al., 2016; Samuels et al., 2012; Sajjadi et al., 2006; Lashutka et al., 2004). 
It may be explained as a byproduct of the ICP-driven changes in C revealed here since 
the two parameters are inversely related according to the Goldmann equation. Baseline 
measurements of C were reproducible following acute ICP elevations, indicating that the 
ICP effect is reversible within the timeframes of this study. Specifically, the ICP effect did 
not persist more than 30 minutes after ICP was returned to baseline. C was found to 
decrease in proportion to ICP for elevations up to 15 mmHg. Perhaps this is because 
TLPD restoration can be achieved by small adjustments to C when ICP elevations are 
minimal; but significant disruptions of the TLPD require more significant outflow 
accommodation. 
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It has been previously reported that euthanization alone does not significantly 
affect C in rats (Ficarrotta et al., 2018). This result was exploited to test whether the ICP 
effect was passive or physiological. Reduced C did not persist at elevated ICP in 
euthanized animals, which supports the hypothesis for the physiological nature of this 
ostensibly protective effect. Furthermore, it is plausible that the TLPD is regulated by the 
sympathetic nervous system due to the extensive autonomic innervation of the eye 
(Niedermeier, 1950; Bloomfield, 1947). To specifically test whether the ICP effect involved 
voltage-gated sodium channel activity, TTX was topically administered to the eye as an 
alternative to euthanization in some animals. The ICP effect did not persist in live eyes 
instilled with TTX even at elevated ICP. These results may indicate the presence of a 
neurally-modulated protective feedback mechanism for maintaining a homeostatic TLPD.  
A working model of TLPD homeostasis has been proposed and is presented in 
Figure 5.10. First, ICP is experimentally elevated which disturbs the TLPD and increases 
the risk for damage at the optic nerve head. Next, neural signaling initiates a reduction in 
C. Finally, IOP increases as a result of reduced aqueous outflow and a homeostatic TLPD 
is restored. One recent study showed that IOP and ICP are controlled by the same group 
of neurons in the hypothalamus of the brain (Samuels et al., 2012). The feedback 
mechanism proposed in this study requires a neural network for communication between 
these pressure compartments; thus, additional experiments to determine whether the 
hypothesized neural feedback mechanism involves processing in the hypothalamus may 
be worthwhile. 
Limitations of this study include the underlying assumptions of the Goldmann 
equation as previously discussed (Ficarrotta et al., 2018). The Goldmann equation 
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assumes only C is pressure dependent and that pressure-flow relationships are linear. 
The potential effects of inaccuracies in these assumptions were described in detail in 
Chapter 2. Additionally, the experiments described in this study were performed on rats 
under general anesthesia. While this is standard practice in outflow research in living 
animals, anesthesia may limit the applicability of our results to conscious animals. This is 
of particular importance for experiments involving TTX, as the effects of ketamine and 
xylazine compounded with TTX on sympathetic ocular innervation have not been 
previously investigated and are beyond the scope of this study. Ideally, the experiments 
described in this chapter would be repeated in conscious animals. Fortunately, Chapter 
4 describes methods for measuring C in conscious rats for the first time using manometric 
techniques. Modifications to Chapter 3 and Chapter 4 methodology could facilitate 
investigations of the effects of elevated ICP on C in conscious animals. 
Recommendations for future work related to this project are provided in Chapter 6.  
This study is the first to investigate the effects of experimentally elevated ICP on 
C in rats. A protective neural feedback mechanism for modulating C to maintain a 
homeostatic TLPD has been proposed. Observations from this study may indicate that 
failure of TLPD homeostatic mechanisms may lead to the glaucoma development. The 
results of this study support CSF theory and the paradigm-shifting concept that the TLPD, 
rather than IOP alone, should be considered as a diagnostic marker and therapeutic 
target in future glaucoma studies.  
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Figure 5.1 Cerebrospinal fluid theory. The upper panel depicts the locations of CSF 
within the brain, spinal cord, and eye. There is a net balancing force controlled by the 
anteriorly directed ICP and posteriorly directed IOP at the lamina cribosa which 
determines the TLPD (TLPD = IOP – ICP). The lower panel depicts relative magnitudes 
of ICP and IOP for normal, glaucomatous, and hypertensive eyes. 
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Figure 5.2 Experimental setup. Intraocular pressure (IOP), intracranial pressure (ICP), 
and mean arterial pressure (MAP) were simultaneously recorded with separate pressure 
sensors via cannulas inserted in the anterior chamber of the eye, lateral ventricles, and 
femoral artery, respectively. The IOP cannula was also connected to a pump that infused 
artificial aqueous humor (AAH) under computer control in order to measure the aqueous 
humor dynamics of the eye, while the ICP cannula was also connected to a variable-
height reservoir of physiological saline in order to manipulate ICP level. 
 
 
Figure 5.3 Cerebral ventricle cannula localization. Coronal tissue sections of a dye-
perfused rat brain. Arrowheads indicate clumps of green dye molecules, which are found 
in the ventricles but not in brain tissue. 
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Figure 5.4 IOP, ICP, and MAP records. Pressure records are simultaneously presented 
for an anesthetized animal before and after 15 mmHg ICP elevation. The white bar 
demarks the time period during which the pump duty cycle required to hold IOP at different 
levels was measured in order to estimate C at resting ICP. Outflow facility was 
subsequently estimated at elevated ICP, producing a similar record that is not shown. 
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Figure 5.5 Impact of elevated ICP on C. (A) Flow (as measured by pump duty cycle) 
required to hold IOP of an individual rat eye at different levels while ICP rested at 4 mmHg 
(black symbols) and was held at 19 mmHg (white symbols). C was 0.020 [0.020, 0.021] 
μL/min/mmHg at resting ICP and 0.011 [0.010, 0.011] μL/min/mmHg at elevated ICP. (B) 
Average C for all animals at resting ICP and 15 mmHg above resting ICP (n = 15). Lines 
are linear regression fits of the data. Error bars represent standard deviation. Asterisks 
indicate statistically significant differences (p < 0.001). 
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Figure 5.6 Baseline C measurements are reproducible. Pressure-flow data from an 
individual animal before (black symbols), during (white symbols), and after (gray symbols) 
elevating ICP by 15mmHg. C was not significantly different pre- and post-ICP elevation 
in any animal (ANCOVA, p > 0.17 for all comparisons). Lines are linear regression fits of 
the data. Error bars represent standard deviation. 
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Figure 5.7 Graded effect of ICP on outflow facility. (A) Pressure-flow data of a rat eye 
at resting ICP (black symbols) and 5 mmHg (dark gray symbols), 10 mmHg (light gray 
symbols), and 15 mmHg (white symbols) above resting ICP. (B) Measured outflow facility 
as a function of ICP elevation. The relationship between C and ICP elevation is 
approximately linear as indicated by an R2 value of 0.991. Lines are regression fits of the 
data. Error bars represent standard deviation (A) or standard error of slope estimates 
from regression analysis (B).  
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Figure 5.8 ICP effect requires an active physiological process. (A) Pressure-flow data 
of a rat eye at resting ICP (black symbols), at 15 mmHg above rest (white symbols), and 
at 15 mmHg above rest following animal euthanasia (gray symbols). (B) Average C for all 
animals each condition (n = 9). Lines represent regression fits of the data. Error bars 
represent standard deviation. Asterisks indicate statistically significant differences from 
baseline measurements (p < 0.001). 
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Figure 5.9 TTX blocks the ICP effect. (A) Pressure-flow data of a rat eye at resting ICP 
(black symbols), at 15 mmHg above rest (white symbols), and at 15 mmHg above rest 
following TTX application to the eye (gray symbols). (B) Average C for all animals at 
elevated ICP pre- and post-TTX application (n = 4). Asterisk indicates statistically 
significant differences from baseline measurements (p < 0.01). (C) Pressure-flow data of 
a rat eye at resting ICP before (black symbols) and after (gray symbols) TTX application 
to the eye. (D) Average C for all animals pre- and post-TTX application (n = 3). Lines are 
regression fits of the data. Error bars represent standard deviation. 
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Figure 5.10 Working model of TLPD homeostasis. The hypothesized underlying 
mechanisms of the ICP effect are shown over time, from left to right, in panels A – D. (A) 
IOP and ICP are both normal which results in a normal TLPD. (B) ICP is experimentally 
elevated and clamped at 15 mmHg above its resting level, which disrupts the TLPD and 
increases the risk of permanent damage at the optic nerve head. (C) A neural signal 
(green arrows) initiates a significant reduction in C. (D) IOP increases as a result of 
reduced outflow through the conventional pathway, thus restoring a normal TLPD and 
sparing the optic nerve head. Relative magnitudes of IOP and ICP are represented by 
size of blue (ICP) and orange (IOP) arrows.  
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Chapter 6: Conclusions 
 
6.1 Summary of Results 
This dissertation describes a novel experimental model of glaucoma and 
quantitatively assesses physiological parameters of aqueous humor dynamics in healthy, 
glaucomatous, and intracranial hypertensive Brown-Norway rat eyes. This work 
advances the current understanding of IOP regulation in healthy animals and during 
conditions related to prevalent human diseases which have not been previously 
investigated, as the necessary systems and methods were lacking prior to their 
development in this work. The results presented in this dissertation demonstrate that 
while impaired aqueous humor drainage causes ocular hypertension in glaucoma, the 
reverse is not explicitly true. Namely, moderate ocular hypertension does not intrinsically 
cause significant injury to nor impairment of trabecular meshwork function. Furthermore, 
this work supports the parading-shifting concept that reduced ICP may be a modifiable 
risk factor for glaucoma: a disease previously thought to have only one modifiable risk 
factor for which all current therapies are directed. Thus, ICP may prove to be both an 
effective diagnostic marker and therapeutic target to help slow or prevent irreversible 
blindness in the tens of millions of individuals who are affected by the disease. A summary 
of the major results of this dissertation work is provided below.   
Chapter 2 quantifies the physiological parameters of aqueous humor dynamics for 
the first time in healthy Brown-Norway rats and presents a novel perfusion technique, the 
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mCP perfusion technique, for measuring these parameters accurately and efficiently. 
Understanding IOP regulation in healthy eyes is a critical first step towards better 
recognizing and understanding IOP dysregulation in diseased eyes. This chapter is not 
simply an extension of existing methodologies to rats, however. The novel perfusion 
technique is presented mathematically and experimentally validated by comparison to 
results from a well-established technique. Statistical analyses show that the mCP 
technique yields indistinguishable results in approximately half the time, making it more 
suitable for serial measurements in living animals, namely anesthetized or conscious 
animals, during which time is a significant experimental constraint. The effects of 
hydration on the eye were thoroughly investigated and shown to complicate measurement 
of unconventional outflow rate. This indicates that previous in-situ estimates of Fun in mice 
are likely contaminated by evaporation effects (Millar et al., 2015; Millar et al., 2011). In a 
novel approach, an ocular shunt was manufactured, characterized, and ultimately 
implanted into the eye to further bolster confidence in the accuracy of C estimates via the 
mCP technique. The absence of detectable washout was a notable finding previously 
observed only in human and mice eyes. 
Chapter 3 describes the CPP model of experimental glaucoma in Brown-Norway 
rats. The development of this model involved the development and characterization of a 
tethered perfusion system for continuously measuring IOP and perfusing AAH into the 
anterior chamber to chronically and unilaterally elevate IOP in conscious animals. The 
relevance of this model to human glaucoma was assessed by quantifying whole numbers 
and distributions of RGCs for various experimental durations, and qualitatively examining 
the globe of the eye, optic nerve, and fundus. Significant RGC loss was observed as early 
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as two weeks following 10 mmHg IOP elevations, and RGC number decayed 
exponentially with increasing time. RGCs in the outer periphery were most susceptible to 
pressure-induced death within the first 4 weeks, yet RGC death was significant across 
the entire retina after 9 weeks of IOP elevation. This pattern resembles patterns of RGC 
death observed in human glaucoma. The globe and fundus appeared normal following 9 
weeks of IOP elevation, while optic nerve cross-sections revealed optic neuropathy 
characteristic of human glaucoma and consistent with established rat models.  
Chapter 4 characterizes aqueous humor dynamics throughout experimental 
glaucoma induced via the CPP model. Resting IOP and C did not significantly vary 
throughout chronic 10 mmHg IOP elevations lasting up to 73 days. POAG pathogenesis 
is thought to involve impaired aqueous drainage which causes ocular hypertension 
secondarily. Moderate levels of ocular hypertension, however, did not inherently induce 
measurable changes in C. Chapter 4 also demonstrates the feasibility of measuring C in 
conscious animals for the first time via the modified tethered perfusion system.  
The effects of ICP elevations on aqueous humor dynamics are investigated in 
Chapter 5. C was significantly reduced when ICP was experimentally elevated by 
approximately 15 mmHg. The increased resistance to conventional outflow was linearly 
graded with ICP elevations up to 15 mmHg and the effect was reversible when ICP was 
returned to baseline. A slight but significant increase in resting IOP was also observed. 
The effect did not persist, however, in live eyes instilled with TTX or in the eyes euthanized 
animals. From these results, we propose a neural feedback mechanism for maintaining 
a homeostatic TLPD across the lamina cribosa. Failure of TLPD homeostatic capabilities 
may be detrimental to RGCs and the optic nerve. 
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6.2 Recommendations for Future Work 
The following subsections describe recommendations for future work related to 
this dissertation. Various recommendations for additional experiments are provided for 
each project and organized accordingly. 
6.2.1 Aqueous Humor Dynamics of the Brown-Norway Rat  
 Chapter 2 reports C, Fun, and IOP in healthy rats; however, EVP and Fin could not 
be discriminated from pressure-flow data alone. Attempts were made to directly measure 
EVP via previously described techniques (Aihara et al., 2003; Millar et al., 2011) without 
success. Developing an accurate technique for measuring either Fin or EVP would allow 
each of the five parameters of the Goldmann equation to be reported individually and 
provide a complete profile of AH dynamics in individual animals. 
 The relationship between net outflow rate, F, and IOP could be more thoroughly 
explored in future studies. Specifically, pressure-flow data could be measured for very 
small IOP or pump rate increments (2 mmHg and 0.04 µl/min, for example) and across a 
wider range of pressures (from resting IOP to IOP = 70 mmHg, for example) to investigate 
whether or at what point the linear pressure-flow relationship becomes compromised. 
Some outflow studies performed in enucleated eyes observed a non-linear relationship 
between pressure and flow, particularly at high pressures (Sherwood et al., 2016; 
Madekurozwa et al., 2017). While a linear pressure-flow relationship was observed across 
the pressure range explored in the work, a thorough examination of this relationship may 
be worthwhile. 
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6.2.2 The Constant-Pressure Perfusion Model of Experimental Glaucoma in Rats 
 The tethered perfusion system can be utilized for various applications of glaucoma 
research, expanding far beyond what has been presented in this dissertation. The ability 
to precisely prescribe, continuously measure, and easily manipulate IOP gives rise to 
experiments that were not previously possible. Chapter 3 characterizes whole numbers 
and patterns of RGC death for 10 mmHg IOP elevations; however, the system’s ability to 
easily vary IOP and exert hydrostatic pressures of different magnitudes should be 
exploited in future research. IOP elevations of 10 mmHg are considered moderate in 
POAG and ocular hypertension, as discussed in Chapter 3. There are, however, distinct 
groups of patients who experience relatively mild or extreme IOP elevations. Whole 
numbers and patterns of RGC loss should thus be characterized in time for different levels 
of IOP elevation to more comprehensively understand patterns of RGC death. For 
example, the experiments described in Chapter 3 could be repeated for IOP elevations 
of 5 mmHg (mild) and 20 mmHg (extreme).  
The eye was pressure-clamped by the AAH reservoir in the experiments described 
in Chapters 3 and 4. Healthy rat eyes exhibit circadian variations in IOP of approximately 
5 mmHg, however (Bello and Passaglia, 2017; Moore et al., 1996). Fortunately, the 
tethered perfusion system offers the ability to manipulate IOP continuously and in real-
time. Therefore, rather than remaining stationary, the AAH reservoir could be positioned 
on a programmable, motorized stage and varied in height to preserve both the period and 
amplitude of normal IOP variations even while IOP is experimentally elevated. 
Alternatively, the AAH reservoir could be replaced by a programmable syringe pump set 
to a pre-determined rate for elevating IOP as desired, based on knowledge from 
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previously collected pressure-flow data (i.e. approximately 0.2 µl/min to elevate IOP by 
10 mmHg). By exerting pressure in this manner (constant-rate rather than constant-
pressure), IOP is free to vary and circadian rhythms should be maintained throughout 
ocular hypertension. Furthermore, a wearable micropump would eliminate the need to 
tether the animal thus improving ease of animal handling. The development of such a 
pump is currently underway in the Ocular Neuroscience and Neuroengineering 
Laboratory at the University of South Florida. 
Furthermore, RGC death could be characterized for patterns of IOP exertion 
beyond circadian rhythms. For example, IOP could be acutely elevated on a regular basis, 
but undisturbed throughout the majority of the experimental duration. RGC number and 
patterns of RGC loss could then be quantified for unique patterns of pressure exertion 
that may result from trauma or as a secondary effect of diseases other than glaucoma. 
Additionally, IOP could be lowered following set durations of chronic IOP elevations to 
determine whether the effects observed in Chapter 4 are reversible.  
The tethered perfusion system allows precise assaying of potential 
neuroprotective drugs. Specifically, experimental neuroprotective drugs can be 
continuously perfused into the eye by direct incorporation into the AAH reservoir. Adding 
drugs to the AAH reservoir is decidedly simple and eliminates the need for regular animal 
handling. RGC survival fraction can then be compared for treated and untreated animal 
groups following identical durations and degrees of IOP elevation. Such experiments 
would serve to precisely evaluate whether potential new therapies can significantly 
protect RGCs or reduce the resulting grade of optic nerve injury. 
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While this dissertation investigated the effect of chronic, unilateral IOP elevations 
on both ocular anatomy and physiology, additional experiments could be performed to 
assess the model’s applicability to clinical glaucoma. Specifically, in this study patterns of 
RGC death were assessed for distinct optic nerve quadrants; however, the orientation of 
these quadrants (i.e. nasal, temporal, superior, inferior) was not known. Fundus images, 
which provide orientation information, could be registered with fluorescent images of the 
retina to determine spatial orientation based on vasculature patterns. This image 
registration could improve our understanding of RGC spatial distribution in different 
quadrants of the retina over time in the rat model. Furthermore, physiological changes 
attributable to the CPP model could be investigated. For example, the ERG, the retina’s 
time-voltage response evoked by various visual stimuli, provides information regarding 
retinal function. Other electrophysiological tests such as the compound action potential 
and visually evoked potential respectively quantify optic nerve and occipital cortex 
function in response to visual stimuli. These electrophysiological tests could be performed 
throughout the CPP model to characterize physiological impairment at various points 
along the visual pathway. Behavioral testing could also be performed to measure the 
visual acuity of implanted animals throughout experimental glaucoma. 
6.2.3 The Effect of Experimental Glaucoma on Aqueous Humor Dynamics in Rats 
This dissertation serially quantifies C and resting IOP in anesthetized animals 
throughout experimental glaucoma. Chapter 4 also discusses the feasibility of using the 
tethered system to measure C in conscious animals. In future studies in both healthy in 
glaucomatous eyes, C would ideally be measured in conscious animals in the absence 
of anesthetics or any additional treatments. The LabVIEW program could even be 
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modified to automatically perform outflow measurements via the mCP or CF technique 
and modified tethered perfusion system in conscious animals. 
Furthermore, a flowmeter could be incorporated into the tethered system to directly 
and continuously measure AAH flow. Along with knowledge of resting IOP and the 
simultaneous IOP record, the AAH flowrate data could be used to generate a continuous 
record of C in time. A continuous C record rather than periodic, discrete measurements 
would improve characterization of C throughout experimental glaucoma. As discussed in 
Chapter 4, C should be measured regularly or even continuously in future studies during 
the first 0 to 7 days of experimental glaucoma to test whether any transient effects are 
detectable during this time. 
6.2.4 The Effect of Intracranial Pressure Elevation on Aqueous Humor Dynamics in 
Rats  
The experiments described in Chapter 5 would ideally be performed in conscious 
animals. Particularly, the effects of the TTX on C and the hypothesized neural feedback 
mechanism should be investigated in the absence of anesthetics, which may contaminate 
our results. The tethered perfusion system could potentially be utilized to achieve this 
goal. A second polyimide tube connected to a saline reservoir and independent pressure 
sensor could be implanted into the lateral ventricle to measure and manipulate ICP and 
IOP in parallel. This experimental design would provide, for the first time, a continuous 
record of the TLPD in conscious animals and facilitate C measurements in conscious 
animals while both IOP and ICP were precisely controlled.  
A significant relationship between elevated ICP and C was established in Chapter 
5. While ICP was exclusively elevated in this study, the effects of depressed ICP on C 
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should also be investigated in future studies. We suspect the resistance of the 
conventional outflow pathway may decrease when ICP is experimentally depressed. In 
general, the limits of conventional outflow accommodation are worth establishing at 
various ICP levels. 
6.3 Closing Remarks 
The model and perfusion systems presented in this dissertation have surpassed 
the project’s originally proposed aims. Specifically, Chapters 3, 4, and 5 describe original 
experiments unlike any work which has been previously performed in humans or other 
animals. One of the most significant contributions of this work is the development of the 
tethered perfusion system and the CPP model of experimental glaucoma. The tethered 
perfusion system offers robust IOP control and precise characterization of whole numbers 
and distributions of RGCs for precise degrees of IOP elevation and experimental 
durations. This technology has the power to significantly advance our understanding of 
glaucoma pathogenesis and progression and to assay potential neuroprotective therapies 
with unmatched precision.  
The ICP effect and associated neural feedback mechanism described in Chapter 
5 are noteworthy findings of this work. The relationship between elevated ICP and C has 
been established for the first time and these results appear to support CSF theory. This 
dissertation suggests ICP may be a modifiable risk factor in glaucoma and should be 
investigated as a potential diagnostic marker and therapeutic target in future studies. The 
presence of a neural feedback mechanism for maintaining a homeostatic TLPD is an 
original, paradigm-shifting proposition in glaucoma research. The contributions of this 
dissertation provide the foundation for various investigative studies aimed at developing 
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clinically translational diagnostic tests and therapies. Given the prevalence of glaucoma 
and its detrimental outcome, the insight gained through this work and recommended 
future work has the potential to positively affect tens of millions of people.  
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Appendix A: Abbreviations 
 
Artificial aqueous humor AAH 
Association for Research in Vision and Ophthalmology ARVO 
Conventional outflow facility C 
Aqueous humor formation rate Fin 
Artificial aqueous humor AAH 
Association for Research in Vision and Ophthalmology ARVO 
Cerebrospinal fluid CSF 
Cerebrospinal fluid pressure CSFP 
Constant-flow CF 
Constant-pressure perfusion CPP 
Conventional outflow facility C 
Episcleral venous pressure EVP 
Inner diameter ID 
Intracranial pressure ICP 
Intraocular pressure IOP 
Left eye OS 
Mean arterial pressure MAP 
Modified constant-pressure perfusion mCP 
Net outflow rate F 
98 
Neutral buffered formalin NBF 
Normal tension glaucoma NTG 
Outer diameter OD 
Phosphate buffered saline PBS 
Polyethylene  PE 
Primary open angle glaucoma POAG 
Pump duty cycle D 
Pump inflow rate Fp 
Retinal ganglion cell RGC 
Right eye OD 
Standard deviation SD 
Standard error SE 
Tetrodotoxin TTX 
Translaminar pressure difference TLPD 
Transmission electron microscopy TEM 
Triton X-100 in phosphate buffered saline PBST 
Unconventional outflow rate Fun 
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Appendix D: Aqueous Humor Dynamics of the Brown-Norway Rat 
 
 This appendix contains the manuscript titled, “Aqueous Humor Dynamics of the 
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